<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">BMC Psychiatry</journal-id><journal-title-group><journal-title>BMC Psychiatry</journal-title></journal-title-group><issn pub-type="epub">1471-244X</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27832747</article-id><article-id pub-id-type="pmc">5105298</article-id><article-id pub-id-type="publisher-id">1109</article-id><article-id pub-id-type="doi">10.1186/s12888-016-1109-x</article-id><article-categories><subj-group subj-group-type="heading"><subject>Study Protocol</subject></subj-group></article-categories><title-group><article-title>Cognitive remediation therapy (CRT) as a treatment enhancer of eating disorders and obsessive compulsive disorders: study protocol for a randomized controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>van Passel</surname><given-names>Boris</given-names></name><address><phone>+31-24-8200 800</phone><email>b.van.passel@propersona.nl</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Danner</surname><given-names>Unna</given-names></name><address><phone>+31-30-6965477</phone><email>u.danner@altrecht.nl</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Dingemans</surname><given-names>Alexandra</given-names></name><address><phone>+31-071 890 33 44</phone><email>a.dingemans@rivierduinen.nl</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>van Furth</surname><given-names>Eric</given-names></name><address><phone>+31-071 890 33 44</phone><email>e.vanfurth@rivierduinen.nl</email></address><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Sternheim</surname><given-names>Lot</given-names></name><address><phone>+31-30-6965477</phone><email>L.C.Sternheim@uu.nl</email></address><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>van Elburg</surname><given-names>Annemarie</given-names></name><address><phone>+31 30 6965477</phone><email>a.van.elburg@altrecht.nl</email></address><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>van Minnen</surname><given-names>Agnes</given-names></name><address><phone>+31-24-8200 800</phone><email>a.van.minnen@propersona.nl</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>van den Hout</surname><given-names>Marcel</given-names></name><address><phone>+31-30-253 1470</phone><email>M.A.vandenHout@uu.nl</email></address><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Hendriks</surname><given-names>Gert-Jan</given-names></name><address><phone>+31-24-8200 800</phone><email>g.hendriks@propersona.nl</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Cath</surname><given-names>Dani&#x000eb;lle</given-names></name><address><phone>+31-30-253 1470</phone><email>d.cath@uu.nl</email></address><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><aff id="Aff1"><label>1</label>Pro Persona, Centre for Anxiety Disorders Overwaal, Institution for Integrated Mental Health Care, Pastoor van Laakstraat 48, Lent, Nijmegen, 6663 CB The Netherlands </aff><aff id="Aff2"><label>2</label>Altrecht Eating Disorders Rintveld, Oude Arnhemseweg 260, Zeist, 3705 BK The Netherlands </aff><aff id="Aff3"><label>3</label>Rivierduinen Eating Disorders Ursula, Sandifortdreef 19, Leiden, 2333 ZZ The Netherlands </aff><aff id="Aff4"><label>4</label>Department of Psychiatry, Leiden University Medical Centre, Einthovenweg 20, Leiden, 2333 ZC The Netherlands </aff><aff id="Aff5"><label>5</label>Altrecht Academic Anxiety Centre, Nieuwe Houtenseweg 12, Utrecht, 3524 SH The Netherlands </aff><aff id="Aff6"><label>6</label>Department of Clinical and Health Psychology, Utrecht University, Heidelberglaan 1, Utrecht, 3584 CS The Netherlands </aff><aff id="Aff7"><label>7</label>Behavioural Science Institute, Radboud University, Montessorilaan 3, Nijmegen, 6525 HR The Netherlands </aff></contrib-group><pub-date pub-type="epub"><day>10</day><month>11</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>10</day><month>11</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>16</volume><elocation-id>393</elocation-id><history><date date-type="received"><day>29</day><month>9</month><year>2016</year></date><date date-type="accepted"><day>1</day><month>11</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2016</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p>Anorexia nervosa (AN) and Obsessive Compulsive Disorder (OCD) are among the most incapacitating and costly of mental disorders. Cognitive Behaviour Therapy (CBT), medication, and combination regimens, to which in AN personalised guidance on weight control is added, are moderately successful, leaving room for more effective treatment algorithms. An underlying deficit which the two disorders share is cognitive inflexibility, a trait that is likely to impede treatment engagement and reduce patients&#x02019; ability to benefit from treatment. Cognitive remediation therapy (CRT) is an easy-to-use intervention aimed at reducing cognitive inflexibility and thereby enhancing treatment outcome, which we aim to test in a controled study.</p></sec><sec><title>Methods</title><p>In a randomized-controlled multicenter clinical trial 64 adult patients with AN and 64 with OCD are randomized to 10 bi-weekly sessions with either CRT or a control condition, after which Treatment As Usual (TAU) is started. All patients are evaluated during single-blind assessments at baseline, post-CRT/control intervention, and after 6 months. Indices of treatment effect are disorder-specific symptom severity, quality of life, and cost-effectivity. Also, moderators and mediators of treatment effects will be studied.</p></sec><sec><title>Discussion</title><p>To our knowledge, this is the first randomized controlled trial using an control condition evaluating the efficacy and effectiveness of CRT as a treatment enhancer preceding TAU for AN, and the first study to investigate CRT in OCD, moreover taking cost-effectiveness of CRT in AN and OCD into account.</p></sec><sec><title>Trial registration</title><p>The Netherlands Trial Register <ext-link ext-link-type="uri" xlink:href="http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=3865">NTR3865</ext-link>. Registered 20 february 2013. </p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Cognitive remediation</kwd><kwd>Anorexia nervosa</kwd><kwd>Obsessive compulsive disorder</kwd><kwd>Psychological treatment</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001826</institution-id><institution>ZonMw</institution></institution-wrap></funding-source><award-id>837001004</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2016</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p>Anorexia nervosa (AN) is a severely debilitating eating disorder characterized by self-starvation with both negative physiological and psychological effects. Individuals with AN assign extreme over-importance to body weight and shape, making it central to their self-evaluation, and develop an abnormal body-image perception.</p><p>Obsessive Compulsive Disorder (OCD) is characterized by recurrent obsessions and compulsions that cause marked distress and interfere with daily functioning [<xref ref-type="bibr" rid="CR1">1</xref>]. More specifically, obsessions are defined as intrusive, repetitive thoughts, images, or impulses, and compulsions as purposeful, repetitive overt and covert behaviours performed to relieve obsessional distress.</p><p>Several studies have investigated potential relationships between AN and OCD based on the phenotypic features the two disorders have in common, such as repetitive and ritualistic behaviours, excessive habit formation, and cognitive rigidity [<xref ref-type="bibr" rid="CR2">2</xref>]. Interestingly, several studies demonstrated rates of AN among OCD patients, and reversely rates of OC symptoms among AN patients to be higher than expected by chance, with OCD frequencies ranging between 9,5 and 62 % in patients with AN, and anorexia nervosa-rates up to 11&#x02013;13 % in clinical OCD populations [<xref ref-type="bibr" rid="CR3">3</xref>&#x02013;<xref ref-type="bibr" rid="CR8">8</xref>].</p><p>Further, there is accumulating evidence that patients suffering from AN and OCD share specific inefficiencies in executive functioning affecting attention processes, set-shifting/cognitive flexibility, processing speed, visuospatial abilities, inhibition of ongoing cognitive and motor responses, and working memory [<xref ref-type="bibr" rid="CR9">9</xref>&#x02013;<xref ref-type="bibr" rid="CR14">14</xref>]. Specific inefficiencies in executive functioning are central to the development and maintenance of obsessions and compulsions as seen in both AN and OCD [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>].</p><p>It is suggested that particularly cognitive inflexibility maintains and exacerbates compulsive behaviours in both AN and OCD [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. Some degree of cognitive inflexibility is also found in first-degree relatives [<xref ref-type="bibr" rid="CR19">19</xref>&#x02013;<xref ref-type="bibr" rid="CR21">21</xref>], i.e. a difficulty to shift to a different thought or action according to changes in a situation [<xref ref-type="bibr" rid="CR22">22</xref>]. These inefficiencies are associated with the neurobiological (fronto-striatal) abnormalities associated with repetitive behaviours in AN and OCD [<xref ref-type="bibr" rid="CR23">23</xref>]. Thus, patients seem to rely heavily on low-energy but highly automated and stereotyped repetitive behaviours, at the cost of higher-energy but more diverse goal-directed and flexible behaviours [<xref ref-type="bibr" rid="CR24">24</xref>].</p><p>Furthermore, individuals with AN show a cognitive style in which there is a bias towards local or detailed-focus processing of information over the natural tendency to integrate information into a for the person relevant context [<xref ref-type="bibr" rid="CR25">25</xref>]. In line with this, individuals with OCD show inefficiencies in global information processing and a detailed and less systematic organizational strategy [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>].</p><p>Finally and consistent with previous research, adults suffering from AN and OCD show specific visuospatial memory inefficiencies [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>].</p><p>Arguably, these inefficiencies may prevent patients from successfully engaging in therapy and may decrease both treatment motivation and the efficacy of psychological interventions.</p><sec id="Sec2"><title>Symptom-based treatment for OCD and AN</title><p>Treatment schemes for AN and OCD are generally aimed at symptom reduction. Standard treatment of adult AN consists of a combination of renourishment and psychotherapy. Clinical effects of either supportive clinical management, CBT, focal psychodynamic therapy, family therapy, or interpersonal psychotherapy are comparable [<xref ref-type="bibr" rid="CR30">30</xref>&#x02013;<xref ref-type="bibr" rid="CR32">32</xref>]. Only 46% of patients recover fully, one third achieves partial improvement (showing residual symptoms), and 20% remains chronically ill [<xref ref-type="bibr" rid="CR33">33</xref>]. One significant challenge in the treatment of individuals with AN concerns the ambivalence towards treatment. Intrinsic motivation to enable behavioural changes is often low [<xref ref-type="bibr" rid="CR34">34</xref>].</p><p>According to European guidelines, the treatment of OCD should typically encompass CBT usually in combination with pharmacotherapy, specifically selective serotonin reuptake inhibitors (SSRIs) [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. Despite reasonable effect sizes (Cohen&#x02019;s d around 1.0) [<xref ref-type="bibr" rid="CR37">37</xref>&#x02013;<xref ref-type="bibr" rid="CR39">39</xref>], only 22% of OCD patients having received CBT recovers completely [<xref ref-type="bibr" rid="CR37">37</xref>]. In a recent meta-analysis, Sharma et al. [<xref ref-type="bibr" rid="CR40">40</xref>] found that 47% of all patients with OCD (treated or untreated) do not achieve complete remission. Thus, rates of incomplete recovery and treatment resistance remain relatively high [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR42">42</xref>].</p><p>Moreover, in OCD non-compliance as to pharmacotherapy is common, as is dropout from CBT (with attrition rates between 13 and 27%) [<xref ref-type="bibr" rid="CR43">43</xref>&#x02013;<xref ref-type="bibr" rid="CR47">47</xref>]. Dropout rates from treatment in outpatients with AN are even higher (ranging from 48 to 100%) [<xref ref-type="bibr" rid="CR48">48</xref>].</p><p>Clearly, optimizing therapy results for AN and OCD remains a major challenge for both researchers and therapists. In the past decades various attempts have been made to develop supportive interventions to enhance adherence and effectivety, with an increasing interest in approaches that target underlying inefficiencies instead of the main symptoms of the disorder itself.</p><p>The relatively low success rates of guideline-directed therapies for AN and OCD, together with the inefficiencies in executive functioning that sufferers seem to share, have prompted the notion that patients might benefit from a training module that addresses and remediates these underlying inefficiencies.</p></sec><sec id="Sec3"><title>Cognitive remediation therapy</title><p>Recently, a cognitive intervention, i.e. Cognitive Remediation Therapy (CRT) has been adapted for eating disorders including AN, which specifically focuses on improving the cognitive inflexibility and organizational inefficiencies described above [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR50">50</xref>]. CRT was originally developed for the treatment of patients with traumatic brain injuries but has also been applied in patients with attention deficit hyperactivity disorder (ADHD), learning disabilities [<xref ref-type="bibr" rid="CR51">51</xref>] and schizophrenia. Although in schizophrenia results have been mixed, symptom reduction as well as improvement of cognitive and social functioning, and normalisation of neural activity have been described [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR53">53</xref>]. CRT aims at improving cognitive flexibility, central coherence, global information processing, reducing perfectionism and improving the awareness of dysfunctional thinking styles.</p><p>In CRT for AN, patients carry out cognitive excercies and are encouraged to reflect on their typical, maladaptive daily-life strategies, and to consider and practice helpful alternatives, for instance by adopting more global &#x02018;bigger-picture&#x02019; thinking strategies and more goal-directed behaviours. A recent meta-analysis on all available case reports has shown that CRT improves the cognitive performance of patients with severe AN and that the intervention is feasible and well tolerated [<xref ref-type="bibr" rid="CR54">54</xref>]. Three recent randomized controlled trials (RCTs) similarly found evidence of its effectiveness in AN [<xref ref-type="bibr" rid="CR55">55</xref>&#x02013;<xref ref-type="bibr" rid="CR57">57</xref>]. Dingemans et al. [<xref ref-type="bibr" rid="CR57">57</xref>] demonstrated CRT preceding TAU to be more effective than TAU alone: the intervention boosted improvement in terms of ED-specific health-related quality of life (QoL) indices (Cohen&#x02019;s d: 1.36), while ED-related psychopathology was lower at follow-up than it was following TAU alone (Cohen&#x02019;s d: 0.99). Patients with relatively poor baseline set-shifting abilities showed greater long-term improvements in quality of life in the CRT group when compared to the control group. The authors accordingly concluded that CRT shows promise as a treatment enhancer. Although CRT has not directly been studied in OCD, two RCTs in OCD have tested similar approaches in OCD. Starting from the hypothesis of strengthening executive functions to foster later symptom reduction, Buhlman et al. [<xref ref-type="bibr" rid="CR58">58</xref>] investigated a cognitive retraining program aimed at reducing organizational inefficiencies. Both OCD and control participants who underwent training improved more in organization and memory than participants who did not receive organizational training. The authors concluded that in OCD organizational capacities can be augmented. They however did not study the effects of this training on OCD symptoms. Second, in a promising RCT on the effects of a cognitive training program to improve organizational skills in 15 OCD patients compared to 15 controls, Park et al. [<xref ref-type="bibr" rid="CR59">59</xref>] found that visual memory functions and obsessive-compulsive symptoms improved more in the treated group than in the control group.</p></sec></sec><sec id="Sec4"><title>Methods/design</title><p>The study design is reported in line with the SPIRIT 2013 Statement (Standard protocol Items: Recommendations for Interventional Trials) [<xref ref-type="bibr" rid="CR60">60</xref>]. The Medical Ethics Committee of the University Medical Centre Utrecht has approved the study (METc no. NL43751.041.13 v.03).</p><sec id="Sec5"><title>Study aims</title><p>The primary goal of the current ongoing study is to examine the treatment enhancing effect of CRT on treatment as usual (TAU, guideline directed therapy) in AN and OCD. The secondary aim is to investigate the cost-effectiveness and budget impact of CRT. The third aim is to study which patient characteristics determine positive benefits from CRT-based treatment enhancement. More specifically, we study several moderators and mediators of response (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Measures to assess screening, outcome, mediator and moderator variables</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Function</th><th>Measure</th><th>Instrument</th><th>T0</th><th>T1</th><th>T2</th><th>T3</th></tr></thead><tbody><tr><td>Screening</td><td>Diagnostic status</td><td>SCID</td><td>X</td><td/><td/><td/></tr><tr><td rowspan="2">Primary outcome</td><td>AN severity</td><td>EDE-Q</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td>OCD severity</td><td>Y-BOCS</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td rowspan="8">Secondary outcome</td><td>OCD severity</td><td>OCI-R</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td rowspan="3">Quality of life</td><td>EQ-5D</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td>ED-Qol <sup>c</sup>
</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td>OCD-Qol <sup>b</sup>
</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td>Daily functioning</td><td>WSAS</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td>Healthcare utilization and production loss</td><td>TIC-P</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td>Depression</td><td>BDI-II</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td>General anxiety</td><td>BAI</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td rowspan="10">Mediators</td><td rowspan="3">Cognitive flexibility</td><td>Stroop</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td>D-Flex</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td>TMT</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td>Response inhibition</td><td>SSRT</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td>Central coherence</td><td>GEFT</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td>Intolerance of uncertainty</td><td>IUS</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td>Perfectionism</td><td>CPQ</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td>Self-efficacy</td><td>PEPPI-5</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td>Behaviour inhibition/activation</td><td>BISBAS</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td>Therapeutic engagement</td><td>SRS <sup>a</sup>
</td><td>X</td><td/><td/><td/></tr><tr><td rowspan="7">Moderators</td><td>Demographics, e.g. sex, age, education level</td><td>Interview</td><td>X</td><td/><td/><td/></tr><tr><td>Diagnostic status</td><td>SCID-I</td><td>X</td><td/><td/><td/></tr><tr><td>Obsessive compulsive personality disorder</td><td>SCID-II-OCPD</td><td>X</td><td/><td/><td/></tr><tr><td>Autism</td><td>AQ</td><td>X</td><td/><td/><td/></tr><tr><td>ADHD</td><td>CAARS-S:SV <sup>b</sup>
</td><td>X</td><td/><td/><td/></tr><tr><td>Cognitive flexibility</td><td>ID/EDS <sup>b</sup>
</td><td>X</td><td/><td/><td/></tr><tr><td>Planning ability</td><td>BADS-Zoo-map</td><td>X</td><td/><td/><td/></tr></tbody></table><table-wrap-foot><p>
<italic>EDQ</italic> Eating Disorder Examination Questionnaire, <italic>Y-BOCS</italic> Yale-Brown Obsessive Compulsive Scale, <italic>OCI-R</italic> Obsessive-Compulsive Inventory-revised, <italic>EQ-5D</italic> EuroQuol, <italic>ED-Qol</italic> Eating Disorder Quality of life questionnaire, <italic>OCD-Qol</italic> Obsessive-Compulsive Disorder Quality of life questionnaire, <italic>WSAS</italic> Work and Social Adjustment Scale, <italic>TIC-P</italic> Trimbos/iMTA Questionnaire for Cost Associated with Psychiatric Illness, <italic>BDI-II</italic> Beck Depression Inventory, second revision, <italic>BAI Beck</italic> Anxiety Inventory, Stroop Stroop task, <italic>D-FLEX</italic> Detail and Flexibility Questionnaire, <italic>TMT</italic> Trail making test, <italic>SSRT</italic> Stop Signal Reaction Task, <italic>GEFT</italic> Group embedded figures Test, <italic>IUS</italic> Intolerance of uncertainty scale, <italic>CPQ</italic> Clinical perfectionism questionnaire, <italic>PEPPI-5</italic> Perceived Efficacy in Patient-Physician Interactions, <italic>BISBAS</italic> Behavioural Inhibition and Behavioural Activation Scales, <italic>SRS</italic> Session Rating Scale, <italic>SCID-I</italic> Structured Clinical Interview for DSM-IV-TR Axis I disorders, <italic>SCID-II</italic> Structured Clinical Interview for DSM-IV-TR Axis II disorders, section obsessive-compulsive personality disorder, <italic>AQ</italic> Autism-spectrum Quotient, <italic>CAARS-S:SV</italic> Connors&#x02019; Adult ADHD Rating Scales, self report, short version, <italic>ID/EDS</italic> Intra dimensional-/extra dimensional shift paradigm, <italic>BADS-Zoo</italic> map Behavioural Assessment of the Dysexecutive Syndrome, Zoo Map</p><p>
<sup>a</sup> after each CRT/SAT session</p><p>
<sup>b</sup> OCD Only</p><p>
<sup>c</sup> AN Only</p></table-wrap-foot></table-wrap>
</p><p>Our research questions read as follows:<list list-type="order"><list-item><p>To what extend does CRT prior to TAU for AN and CBT for OCD enhance treatment outcome?</p></list-item><list-item><p>To what extend is addition of CRT to TAU more cost-effective?</p></list-item><list-item><p>What are moderators of treatment-enhancing effect of CRT in AN and OCD?</p></list-item><list-item><p>What are mediators of treatment-enhancing effect of CRT in AN and OCD?</p></list-item></list>
</p></sec><sec id="Sec6"><title>Design</title><p>Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> provides an overview of the study design. In a randomized controlled multicentre trial, we compare two treatment arms, i.e. CRT and, in the control condition, Specialized Attention Therapy (SAT), both delivered in 10 twice weekly sessions as an adjunct to TAU for AN and OCD. Patients are assessed at baseline (T0), directly following CRT or SAT completion and prior to symptom based TAU (T1), at 6 months after T0; (T2), and at 12 months after T0 (T3). All patients receive both oral and written information and are enrolled after they have provided written informed consent.<fig id="Fig1"><label>Fig. 1</label><caption><p>Study design</p></caption><graphic xlink:href="12888_2016_1109_Fig1_HTML" id="MO1"/></fig>
</p></sec><sec id="Sec7"><title>Participants</title><p>Patients aged between 18 and 60 years are recruited from four Dutch tertiary clinics specialized in the treatment of anxiety and eating disorders. Patients diagnosed with AN (both restrictive and binge/purge subtype) are recruited from Altrecht Eating Disorders Rintveld, Zeist, and Rivierduinen Eating Disorders Ursula, Leiden, and patients with OCD from Altrecht Academic Anxiety Centre, Utrecht, and Overwaal Centre for Anxiety Disorders, Nijmegen. Most of the patients referred to these centres suffer from moderate to severe AN or OCD.</p><p>Eligible are patients whose AN (or eating disorder not otherwise specified, clinically referred to as AN) or OCD diagnosis is consistent with the Diagnostic and Statistical Manual of Mental Disorders, fourth edition text revision (DSM-IV-TR ).</p><p>The criteria for exclusion are: severe neurological illness (including a history of seizures, stroke, or Parkinson&#x02019;s disease), severe comorbid psychiatric disorder (clinical significant major depressive disorder, current acute phase of bipolar disorder, current psychosis, substance dependence/abuse), intellectual impairment, defined as an IQ&#x02009;&#x0003c;&#x02009;80, estimated with the Dutch Adult Reading Test (DART) [<xref ref-type="bibr" rid="CR61">61</xref>], which is a Dutch version of the National Adult Reading Test (NART) [<xref ref-type="bibr" rid="CR62">62</xref>], and inability to adequately speak or read Dutch. Current use of antidepressants and antipsychotics is allowed provided that dosages are kept constant during the experimental part of the study. Since benzodiazepines can dampen the effect of cognitive treatments [<xref ref-type="bibr" rid="CR63">63</xref>], their use is restricted to a daily maximum dose (up to 20 mg for temazepam or an equivalent dose) taken as a sleep medication. On request, patients can withdraw their participation at any time.</p><p>Inclusion and exclusion criteria are verified with the aid of the structured clinical interview for DSM-IV-TR axis I disorders (SCID-I [<xref ref-type="bibr" rid="CR64">64</xref>]), while for OCD patients to be enrolled, a Yale-Brown Obsessive-Compulsive Severity Scale score &#x02265;16 is required [<xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR66">66</xref>]. In all patients comorbidity with either OCD or AN is allowed.</p></sec><sec id="Sec8"><title>Procedure and randomization</title><p>All participating centres adhere to standardized intake and screening procedures. The therapist performing the screening informs patients meeting the inclusion criteria about the study and ask their permission to have a research assistant contact them by phone or in person to invite them to participate in the trial, after which interested patients are sent or given a brochure describing the study. At least 1 week later baseline assessments are carried out after written informed consent is obtained. After baseline assessments patients not meeting inclusion-criteria are excluded. Patients satisfying all the study criteria are subsequently randomized to one of the two study conditions. An independent research coordinator who is not involved in the therapies or assessments uses SPSS/IBM [<xref ref-type="bibr" rid="CR67">67</xref>] to create a randomization sequence stratified by treatment centre with a 1:1 allocation using random block sizes of 4. Given the nature of the study design, all patients and therapists are aware of the treatment condition (CRT or SAT). Patients are informed that both treatment arms are being investigated as to their potential to enhance subsequent TAU. The therapists delivering CRT or SAT are instructed not to reveal the treatment condition to the research assistant conducting the assessments; unintended violation of assessor blindness is recorded.</p></sec><sec id="Sec9"><title>Measures</title><p>Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> provides a list of screening, outcome, mediator and moderator measures. Assessments to monitor treatment progress are performed at baseline (T0), after 2 months (post-CRT or SAT and prior to TAU) (T1), and 6 months after the baseline TAU (T2), and after 12 months (T3) This measurement will encompass the same instruments as used at T2. All patients are extensively re-evaluated using (validated or recommended) indices of treatment effect and costs, quality of life, and cognitive and behavioural flexibility, which will entail self-reports, structured clinical interviews, and paper-and-pen as well as computerized neuropsychological tests. All screening and outcome data are collected in a central database using SPSS/IBM [<xref ref-type="bibr" rid="CR67">67</xref>].</p></sec><sec id="Sec10"><title>Screening measures</title><p>The Structured Clinical Interview for DSM-IV-TR Axis I disorders (SCID-I) [<xref ref-type="bibr" rid="CR64">64</xref>] and the Structured Clinical Interview for DSM-IV-TR Axis II disorders (SCID-II) [<xref ref-type="bibr" rid="CR68">68</xref>] are used to assess diagnostic status. The SCID-I [<xref ref-type="bibr" rid="CR64">64</xref>] and SCID-II [<xref ref-type="bibr" rid="CR68">68</xref>] are semi-structured interviews. Both interviews are organized by the DSM-IV classifications. The inter-rater reliability and validity of SCID-I and SCID-II interviews are fair to excellent depending the diagnosis [<xref ref-type="bibr" rid="CR69">69</xref>] For the present study we used the full SCID-I and only the section on obsessive-compulsive personality disorder from the SCID-II.</p></sec><sec id="Sec11"><title>Outcome measures</title><p>The primary outcome measures are: 1) disease-specific psychopathology: Eating Disorder Examination Questionnaire (EDE-Q) [<xref ref-type="bibr" rid="CR70">70</xref>] for AN severity; Yale-Brown Obsessive Compulsive Scale (Y-BOCS) [<xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR66">66</xref>] for OCD severity.</p><p>The Eating Disorder Examination Questionnaire (EDE-Q) [<xref ref-type="bibr" rid="CR70">70</xref>, <xref ref-type="bibr" rid="CR71">71</xref>] is the self-report version of the Eating Disorder Examination (EDE) [<xref ref-type="bibr" rid="CR72">72</xref>], a semi-structured interview to evaluate ED psychopathology. The EDE-Q assesses attitudinal and behavioural aspects of EDs over a 28-day period. It has four subscales assessing concerns about shape, weight and eating, and restraint. The EDE-Q consists of subscale scores and a total scale score. The EDE-Q has excellent internal consistency (Cronbach &#x003b1; 0.78-0.93). The subscales have also excellent test-retest reliability over a 2-week period (Pearson r ranging from 0.81 to 0.94) [<xref ref-type="bibr" rid="CR73">73</xref>].</p><p>The 10-item Yale-Brown Obsessive-Compulsive Severity Scale (Y-BOCS) [<xref ref-type="bibr" rid="CR74">74</xref>] is a clinician-rated, semi-structured interview-based scale that is broadly used to assess obsessive-compulsive symptom severity. The scale has two parts, each with five questions, with each subscale assessing five aspects of OCD pathology: 1) time consumed, 2) degree of interference, 3) distress, 4) resistance, and 5) perceived control. The first subscale gives an obsession score (maximum: 20), the second a compulsion score (maximum: 20), and together yield a total score (maximum: 40). It has a strong internal consistency (Cronbach &#x003b1; .88-.91), inter-rater reliability (r 0.82&#x02013;0.98), and test-retest reliability in clinical and nonclinical samples were excellent.</p><p>The secondary outcome measures are: 1) disease-specific psychopathology: Obsessive-Compulsive Inventory-Revised (OCI-R) [<xref ref-type="bibr" rid="CR75">75</xref>], 2) quality of life and daily functioning: EuroQol (EQ-5D) [<xref ref-type="bibr" rid="CR76">76</xref>], Eating Disorder Quality of life questionnaire (ED-QoL) [<xref ref-type="bibr" rid="CR77">77</xref>], Obsessive Compulsive Disorder Quality of life questionnaire (OCD-QoL) [<xref ref-type="bibr" rid="CR78">78</xref>], and Work and Social Adjustment Scale (WSAS) [<xref ref-type="bibr" rid="CR79">79</xref>], 3) cost-effectiveness (direct and indirect health-related costs as evaluated by means of patients&#x02019; self-reported QoL ratings and medical and societal burden: Trimbos/iMTA Questionnaire for Costs associated with Psychiatric illness (TiC-P) [<xref ref-type="bibr" rid="CR80">80</xref>], 4) general anxiety: Beck Anxiety Inventory (BAI) [<xref ref-type="bibr" rid="CR81">81</xref>], and 5) Depression: Beck Depression Inventory, second revision (BDI-II) [<xref ref-type="bibr" rid="CR82">82</xref>].</p><p>The Obsessive-Compulsive Inventory-revised (OCI-R) [<xref ref-type="bibr" rid="CR75">75</xref>] evaluates the frequency, and distress experienced of OCD symptoms using six subscales: washing, obsessing, hoarding, ordering, checking, and neutralizing. The OCI-R has good psychometric properties [<xref ref-type="bibr" rid="CR75">75</xref>, <xref ref-type="bibr" rid="CR83">83</xref>, <xref ref-type="bibr" rid="CR84">84</xref>] and is sensitive to the effects of treatment [<xref ref-type="bibr" rid="CR85">85</xref>]. Internal consistency was adequate (obsessing &#x003b1;&#x02009;=&#x02009;.82, washing &#x003b1;&#x02009;=&#x02009;.86, checking &#x003b1;&#x02009;=&#x02009;.88, neutralizing &#x003b1;&#x02009;=&#x02009;.86, ordering &#x003b1;&#x02009;=&#x02009;.90, hoarding &#x003b1;&#x02009;=&#x02009;.90, total scale &#x003b1;&#x02009;=&#x02009;.81 ) and test-retest reliability was excellent (Spearman&#x02019;s correlations between .79 and .91) [<xref ref-type="bibr" rid="CR75">75</xref>].</p><p>The EuroQol (EQ-5D) [<xref ref-type="bibr" rid="CR76">76</xref>] is a standardized self-report instrument gauging five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension is rated on three levels (no problems, some problems, and extreme problems). Further, the EQ-5D uses a visual analog scale from 0 to 100, on which the respondent marks his general well-being. The EQ-5D is used in a variety of studies to determine health status in a wide variety of patients.</p><p>The Eating disorder Quality-of-Life questionnaire (ED-QoL) [<xref ref-type="bibr" rid="CR77">77</xref>] generates a disorder-specific self-rated quality-of-life score. It consists of 25 items assessing the influence of eating behaviours/body weight in four subscales: psychological, physical/cognitive, financial, and work/school. A total score is calculated as the average of the items of the four subscales. Higher scores indicate a lower quality of life. The ED-QoL has a good internal consistency (Cronbach &#x003b1;&#x02009;=&#x02009;0.84&#x02013;0.95), and test-retest reliability (intraclass correlations were .97 for the psychological subscale, .87 for the physical/cognitive subscale, .90 for the financial subscale, .14 for the work/school subscale, and .93 for the total score) [<xref ref-type="bibr" rid="CR77">77</xref>].</p><p>The Obsessive-Compulsive Disorder Quality of Life (OCD-QoL) is a self-report questionnaire [<xref ref-type="bibr" rid="CR78">78</xref>] gauging the influence of OCD on the respondent&#x02019;s quality of life. It was adapted from the ED-QOL and thus also has four subscales: psychological, physical/cognitive, financial and work/school, whose 25 items are scored and interpreted similarly.</p><p>The Work and Social Adjustment Scale (WSAS) [<xref ref-type="bibr" rid="CR79">79</xref>] examines to which extent the disorder has caused the patient functional impairment. A total score of 10 or below is normal, with scores of 10&#x02013;20 indicating significant functional impairment but less severe clinical symptomatology, and scores of 20 and above suggest moderate to severe impairment or more severe psychopathology. The test-retest correlation for the total WSAS score was 0.73 and the scale has an acceptable to good internal consistency (Cronbach alpha 0.79&#x02013;0.88).</p><p>The Trimbos/iMTA questionnaire for costs associated with psychiatric illness (TIC-P) [<xref ref-type="bibr" rid="CR80">80</xref>] evaluates the utilization of medical services such as the number of contacts with the general practitioner and other care providers (e.g., medical specialists and paramedics) as well as medication used during the last 3 months. The costs associated with the experimental and control interventions delivered during this study will be calculated as recommended in the Dutch handbook on cost calculations in health care [<xref ref-type="bibr" rid="CR86">86</xref>]. Reference unit prices of corresponding health-care services will be used and cost-utility calculated by relating the difference in direct medical costs per patient receiving CRT&#x02009;+&#x02009;TAU and SAT&#x02009;+&#x02009;TAU to the difference in terms of quality-adjusted life years (QALY) gained (cost-utility), yielding a QALY estimate.</p><p>The Beck Depression Inventory, second revision (BDI-II) [<xref ref-type="bibr" rid="CR82">82</xref>] is a gold-standard self-report measure to assess the severity of depressive symptoms. The BDI-II comprises 21 categories of statements. Respondents are asked to choose the statement that describes the way they felt in the past 2 weeks. Each item is rated on a 4-point Likert-type scale ranging from 0 to 3, with higher scores indicating higher levels of depression. The maximum total score for all 21 items is 63. Score categories range from 0 to 13 (minimal depression), 14 to 19 (mild depression), 20 to 28 (moderate depression), and 29 to 63 (severe depression). The BDI-II has good psychometric properties [<xref ref-type="bibr" rid="CR87">87</xref>]. The BDI-II shows good validity compared to the Hamilton Depression Rating Scale (Pearson&#x02019;s r of 0.71). The inventory has high internal consistency (Cronbach &#x003b1;&#x02009;=&#x02009;.91) [<xref ref-type="bibr" rid="CR88">88</xref>].</p><p>The Beck Anxiety inventory (BAI) [<xref ref-type="bibr" rid="CR81">81</xref>] gauges symptoms of anxiety (such as trembling hands, dizziness, sweating) by means of 21 questions. Respondents indicate if and to what extent they have experienced any symptoms during the past week on a 4-point Likert scale ranging from 0 (not at all) to 3 (severely). The BAI discriminates well between anxious and non-anxious groups and is useful as screening measure for anxiety in a variety of clinical populations. The BAI has a high validity and high internal consistency (&#x003b1; .92).</p></sec><sec id="Sec12"><title>Mediators</title><p>The following variables will be tested as potential mediators of intervention response: 1) cognitive flexibility, using a Stroop task [<xref ref-type="bibr" rid="CR89">89</xref>], including Delis-Kaplan Executive Function System (D-KEFS) card nr. 4, as well as Detail and Flexibility Questionnaire (D-Flex) [<xref ref-type="bibr" rid="CR90">90</xref>], Trail Making Test (TMT) [<xref ref-type="bibr" rid="CR91">91</xref>], 2) response inhibition: Stop Signal Reaction Task (SSRT) [<xref ref-type="bibr" rid="CR92">92</xref>], 3) Central coherence: Group embedded figures test (GEFT) [<xref ref-type="bibr" rid="CR93">93</xref>], 4) Intolerance of uncertainty: Intolerance of Uncertainty Scale (IUS) [<xref ref-type="bibr" rid="CR94">94</xref>], 5) Perfectionism: Clinical Perfectionism Questionnaire (CPQ) [<xref ref-type="bibr" rid="CR95">95</xref>], 6) Self-efficacy: Perceived Efficacy in Patient-Physician Interactions (PEPPI-5) [<xref ref-type="bibr" rid="CR96">96</xref>], 7) Behavioural Inhibition and Behavioural Activation Scales (BISBAS) [<xref ref-type="bibr" rid="CR97">97</xref>], and 8) therapeutic engagement Session Rating Scale (SRS) [<xref ref-type="bibr" rid="CR98">98</xref>].</p><p>The Stroop-task was originally developed by Stroop [<xref ref-type="bibr" rid="CR89">89</xref>] to easily measure selective attention and cognitive flexibility. The Stroop Color-Word Test has three components. Patients are first asked to name a series of colored words to reflect basic reading rate. They are next asked to name the color (red, blue, or green) of a bar. The final component comprises a Color-Word task in which the participant is shown the names of colors printed in conflicting ink colors (e.g., the word &#x0201c;green&#x0201d; in blue ink) and is asked to name the color of the ink rather than the word. For all tasks, patients are timed by the tester to determine the number of seconds needed to identify all the stimuli, and, for the interference condition, the number of uncorrected errors is recorded. The &#x02018;Stroop Effect&#x02019; is calculated by subtracting the difference between the interference and color patch task times, where lower scores indicate better executive functioning. Average test-retest reliability for the Stroop task is high (<italic>r</italic>&#x02009;=&#x02009;0.84) [<xref ref-type="bibr" rid="CR99">99</xref>]. In the present study we use the Color-Word interference test from the D-KEFS test-battery [<xref ref-type="bibr" rid="CR100">100</xref>].</p><p>The D-Flex [<xref ref-type="bibr" rid="CR90">90</xref>] is a 24-item self-report scale that measures cognitive rigidity (difficulty with set-shifting/flexibility) and attention to detail (weak central coherence). The two subscales showed high internal consistency (Cronbach &#x003b1; 0.90&#x02013;0.95), construct validity (as compared to relevant subscales of the AQ) was strong for cognitive rigidity (<italic>r</italic>&#x02009;=&#x02009;0.72) but moderate for attention to detail (<italic>r</italic>&#x02009;=&#x02009;0.26).</p><p>The Trail Making Test (TMT) [<xref ref-type="bibr" rid="CR91">91</xref>] is used to evaluate set-shifting abilities. Originally a pen-and-paper test, more recently a computerized version has become available. Patients numerically or alphabetically connect circles on a page in a &#x02018; dot-to-dot &#x02019; fashion (trail A), and then alternatively link numbers and letters, i.e. 1&#x02013;A&#x02013;2&#x02013;B&#x02013;3&#x02013;C (trail B). Time taken to complete trail B (switching task) is the outcome measure of set-shifting ability.</p><p>When performing the computerized Stop Signal Task (SSRT) [<xref ref-type="bibr" rid="CR92">92</xref>] patients need to rapidly select corresponding motor responses to left- or right-facing arrows appearing on a computer screen and attempt to inhibit responses when an auditory &#x0201c;stop signal&#x0201d; sounds. Using a tracking algorithm, the task estimates the time taken to internally suppress prepotent motor responses (stop-signal reaction times).</p><p>The Group Embedded Figures Test (GEFT) [<xref ref-type="bibr" rid="CR101">101</xref>] is a paper-and-pencil task commonly used as a measure of central coherence. The time taken to find 18 simple shapes embedded in complex designs is recorded, with the main outcome being the total time needed to locate all hidden shapes, where shorter times are assumed to result from a strong local processing capacity or a bias toward detail.</p><p>The Intolerance of Uncertainty Scale (IUS) [<xref ref-type="bibr" rid="CR94">94</xref>, <xref ref-type="bibr" rid="CR102">102</xref>, <xref ref-type="bibr" rid="CR103">103</xref>] was developed to assess reactions to ambiguous situations, uncertainty, and future events. The IUS has been investigated and validated in various populations to measure intolerance of uncertainty. The IUS includes 27 items relating to the idea that uncertainty is unacceptable, reflects badly on a person, and leads to frustration, stress, and the inability to take action. Respondents rate items on a 5-point Likert scale ranging from 1&#x02009;=&#x02009;&#x0201c;not at all characteristic of me&#x0201d; to 5&#x02009;=&#x02009;&#x0201c;entirely characteristic of me&#x0201d;. The Dutch version has high internal consistency for anxiety-disordered patients (Cronbach &#x003b1;&#x02009;=&#x02009;0.94) and a satisfactory test-retest reliability (<italic>r</italic>&#x02009;=&#x02009;0.79).</p><p>The Clinical Perfectionism Questionnaire (CPQ) assesses degrees of perfectionism. Respondents are presented with 12 items describing different expressions of perfectionism and asked to rate these on a 4-point Likert scale in relation to the last 28 days. Total score is the sum of all scores and range from 12 to 48, with higher scores indicating higher clinical perfectionism. There is evidence showing the CPQ to be a promising and reliable measure of clinical perfectionism. It has an acceptable internal consistency (Cronbach &#x003b1;&#x02009;=&#x02009;0, 71) and test-retest reliability (<italic>r</italic>&#x02009;=&#x02009;0.49&#x02013;0.67) [<xref ref-type="bibr" rid="CR95">95</xref>, <xref ref-type="bibr" rid="CR104">104</xref>].</p><p>With the Perceived Efficacy in Patient-Physician Interactions (PEPPI-5) [<xref ref-type="bibr" rid="CR96">96</xref>] patients rate their sense of confidence or self-efficacy in regard to their interactions with their physician on a 5-point Likert scale ranging from &#x02018;not at all confident&#x02019; (1) to &#x02018;very confident&#x02019; (5). The instrument has been translated and validated for use in the Netherlands [<xref ref-type="bibr" rid="CR105">105</xref>]. The range of possible scores is 5 to 25, with 25 reflecting highest-level self-efficacy. The PEPPI-5 has a high internal consistency (Cronbach alpha 0.92) and a fair test-retest reliability (intra-class correlation coefficient 0.68).</p><p>The Behavioural Inhibition and Behavioural Activation Scale (BISBAS) [<xref ref-type="bibr" rid="CR97">97</xref>] is a 20-item instrument designed to measure behavioural inhibition (i.e., concern over and reactivity to aversive events) and behavioural activation (i.e., responsiveness to incentives, drive, and fun seeking). Patients respond to the items using a 4-point scale, ranging from 1 (quite untrue) to 4 (quite true). After reverse scoring of two items on the BIS, subscale scores are computed by summing the scores corresponding to items on the BIS scale (7 items, range 7&#x02013;28, &#x003b1; .74). The BAS-scale (13 items, range scores 13&#x02013;52) consists of the reward responsiveness scale (5 items, &#x003b1; .73), the drive scale (4 items, &#x003b1; .76), and the Fun Seeking scale (4 items, &#x003b1; .66). Test-retest correlations over an 8 week period are satisfactory (r from 0.59 to 0.69). The BIS correlates moderately highly with measures of trait anxiety, negative affect, and negative temperament. The BAS correlates positively with extraversion, positive affect, and positive temperament.</p><p>The Session Rating Scale (SRS) [<xref ref-type="bibr" rid="CR98">98</xref>] is a short, 4-item, self-report questionnaire probing therapeutic alliance. After each session patients are asked to give their impressions of the preceding session using a VAS. They rate their bond with the therapist, agreement on therapy goals and therapy tasks, and their confidence in the collaboration, where ratings can range from &#x0201c;there was something missing in the session today&#x0201d; to &#x0201c;Overall, today&#x02019;s session was right for me&#x0201d;. The Dutch translation of the SRS has been shown to have a strong internal consistency (Cronbach alpha 0.85&#x02013;0.95) and adequate test-retest reliability [<xref ref-type="bibr" rid="CR106">106</xref>], although in the Dutch study correlations with outcome and concurrent validity were lower than expected.</p></sec><sec id="Sec13"><title>Moderators</title><p>The following variables will be tested as potential moderators of intervention response: 1) demographic variables (e.g. sex, age, educational level), 2) general psychopathology: Structured Clinical Interview for DSM-IV-TR Axis I disorders (SCID-I) [<xref ref-type="bibr" rid="CR64">64</xref>], Structured Clinical Interview for DSM-IV-TR Axis II disorders, section obsessive-compulsive personality disorders (SCID-II-OCPD) [<xref ref-type="bibr" rid="CR68">68</xref>], 3) Autism: Autism-spectrum Quotient (AQ) [<xref ref-type="bibr" rid="CR107">107</xref>], 4) Attention-deficit hyperactivity disorder: Connors&#x02019; adult ADHD Rating Scales CAARS-S:SV) [<xref ref-type="bibr" rid="CR108">108</xref>], 5) Cognitive flexibility: Intra dimensional-/extra dimensional shift paradigm (ID/EDS) [<xref ref-type="bibr" rid="CR109">109</xref>], and 6) Planning ability: Behavioural Assessment of the Dysexecutive Syndrome, Zoo MAP (BADS-Zoo map) [<xref ref-type="bibr" rid="CR110">110</xref>]. The SSRT, IUS, and BADS-Zoo map will be taken for OCD only.</p><p>The autism-spectrum quotient (AQ) [<xref ref-type="bibr" rid="CR107">107</xref>] is a self-report questionnaire that assesses traits associated with the autistic spectrum [<xref ref-type="bibr" rid="CR111">111</xref>]. It consists of five 10-item subscales (social skills, attention switching, communication, imagination, attention to detail). Example items of the AQ are: &#x0201c;I find myself drawn more strongly to people than to things&#x0201d; and &#x0201c;Trying to imagine something, I find it easy to create a picture in my mind&#x0201d;. Respondent rate each item on a 4-point Likert scale from &#x0201c;definitely agree&#x0201d; to &#x0201c;definitely disagree&#x0201d;. A score of&#x02009;&#x02265;&#x02009;32 is indicative of an autism spectrum disorder. The index&#x02019;s test-retest reliability is good (<italic>r</italic>&#x02009;=&#x02009;.60 to .81) and internal consistency is acceptable (&#x003b1;&#x02009;=&#x02009;.71) [<xref ref-type="bibr" rid="CR112">112</xref>].</p><p>The Connors&#x02019; Adult ADHD Rating Scales self-report, short version (CAARS-S:SV) [<xref ref-type="bibr" rid="CR108">108</xref>] comprises 30 items on the presence of ADHD symptoms to be rated on a 4-point Likert scale ranging from 0 (not at all), to 3 (very much). The maximum score for al 30 items is 90. The CAARS-S:SV consists of 5 subscales (inattention/memory problems, hyperactivity/restlessness, impulsivity/emotional lability, problems with self-concept, and ADHD-index). The internal consistency is good, ranging from &#x003b1;&#x02009;=&#x02009;.80 to .89 and it has an acceptable test-retest reliability (<italic>r</italic>&#x02009;=&#x02009;0.58 to 0.77).</p><p>The Intra-dimensional/extra-dimensional shift task (ID/EDS) [<xref ref-type="bibr" rid="CR109">109</xref>] is part of the Cambridge Neuropsychological Test Automated Battery (CANTAB). The version used in the current trial is a replication of the original task. The ID/EDS is a reliable and valid computerized task, which, like the TMT, probes set-shifting ability [<xref ref-type="bibr" rid="CR113">113</xref>&#x02013;<xref ref-type="bibr" rid="CR115">115</xref>]. The paradigm involves nine-stages of a visual discrimination task with multidimensional stimuli. Two stimuli are displayed, and feedback is provided which stimulus is correct. To pass to the next stage, six consecutive correct responses are required within 50 trials; if not, the task ends. The rule for correct responding is modified at the start of each task stage.</p><p>The Zoo Map is part of the Behavioural Assessment of the Dysexecutive Syndrome test battery (BADS) [<xref ref-type="bibr" rid="CR110">110</xref>] and consists of two parts. In the first part, patients are instructed to plan their route through a map of a zoo, visiting a selection of locations while actively disregarding others. While planning the route, patients also instructed to obey certain rules. The second part consists of the same map with the same locations that have to be visited, but this time, instructions are provided about the precise order in which the locations must be visited. Therefore, in contrast to the first part, the second part consists of a highly structured setting that strongly reduces the involvement of planning abilities. The BADS-Zoo map subtest has been proven to be a valid indicator of planning ability in a heterogeneous patient sample [<xref ref-type="bibr" rid="CR116">116</xref>].</p></sec><sec id="Sec14"><title>Power and sample-size calculation</title><p>In accordance with Cohen [<xref ref-type="bibr" rid="CR117">117</xref>], we calculated the sample sizes needed to detect treatment-specific differences: CRT&#x02009;+&#x02009;TAU vs. SAT&#x02009;+&#x02009;TAU, for which we used software by G-power [<xref ref-type="bibr" rid="CR118">118</xref>].</p><p>We based effect-size calculations on Dingemans&#x02019; first RCT [<xref ref-type="bibr" rid="CR57">57</xref>] comparing CRT&#x02009;+&#x02009;TAU with TAU alone for eating disorders in which they obtained large effect sizes for reduction in eating disorder pathology (Cohen&#x02019;s d: 0.99). Given the control condition in this study we take into account a smaller effect-size. In the case of two-tailed MANOVAs, repeated measures and four within-between interactions (2 groups: AN and OCD), two conditions (CRT&#x02009;+&#x02009;TAU vs. SAT&#x02009;+&#x02009;TAU), three measurements (baseline, and 2, and 6 months after baseline), with alpha&#x02009;=&#x02009;0.05, a sample size of 113 patients is needed to have a power of at least 0.80 to detect an effect size f(V) of 0.25. Although the dropout rate in the previous CRT studies of Dingemans was low (<italic>n</italic>&#x02009;=&#x02009;7 out of 82 patients), we have opted to include an additional 15 patients to compensate for attrition, totalling 128 patients in total (64 CRT&#x02009;+&#x02009;TAU and 64 SAT&#x02009;+&#x02009;TAU).</p></sec><sec id="Sec15"><title>Interventions</title><p>CRT and SAT are both delivered in 10 bi-weekly sessions directly preceding TAU. As AN patients will need to be closely monitored and given nutritional advice throughout the study, the relevant treatment components will be part of the first treatment phase in this group. Other components of (psychological) treatment will not be offered until CRT/SAT has been completed.</p></sec><sec id="Sec16"><title>Cognitive remediation therapy</title><p>In this trial, CRT is based on the Dutch translation of the original manual by Kate Tchanturia [<xref ref-type="bibr" rid="CR119">119</xref>] for both patient groups. Comprising 10 twice weekly 45-min sessions, CRT is delivered by psychologists, clinical nurses, and psychology students (at the MSc level), all having been trained by experienced CRT therapists (UD, BvP, LS, DC) who themselves were trained by Dr Kate Tchanturia, expert on CRT for eating and weight disorders. Using a range of cognitive lab-based exercises, CRT aims at improving patients&#x02019; set-shifting, cognitive flexibility, global information processing skills, and at reducing perfectionism. Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref> lists the within-session exercises used in the RCT.<table-wrap id="Tab2"><label>Table 2</label><caption><p>CRT exercises</p></caption><table frame="hsides" rules="groups"><tbody><tr><td>Central coherence tasks</td><td>Maps<break/>Summarize a letter<break/>Hidden words<break/>Word-search task<break/>Embedded word task</td></tr><tr><td>Set shifting tasks</td><td>Card Stack<break/>Visual illusions<break/>Stroop material<break/>Switching attention task<break/>Switching Time Zones<break/>Alphabet task</td></tr><tr><td>Perfectionism tasks</td><td>Estimation task</td></tr><tr><td>Strategy tasks</td><td>How to plant a sunflower<break/>Complex figure task</td></tr></tbody></table></table-wrap>
</p><p>For a more detailed description of the exercises, see Tchanturia et al. [<xref ref-type="bibr" rid="CR119">119</xref>]. With respect to carrying out the exercises, awareness of dysfunctional thinking styles is enhanced. Patients are encouraged to find out how these thinking styles affect their daily lives, and from session 2 onward, homework assignments are given comprising behavioural exercises that are closely linked to real-life skills and tasks to thus stimulate patients to practice more flexible behaviours in their everyday lives.</p></sec><sec id="Sec17"><title>Specialized Attention Therapy (SAT)</title><p>SAT has been designed as the control intervention specifically for this trial. SAT is delivered by the same health professionals delivering CRT. The SAT session structure (10 twice weekly, 45-min sessions and homework assignment) is the same as in CRT. However, during SAT, cognitive flexibility, central coherence, global information processing skills, awareness of thinking styles, and reducing perfectionism are not addressed. Instead, after each task patients are asked their opinion on whether they (dis)liked the task. As a treatment rationale, patients are explained that SAT aims at helping them to focus on positive experiences by means of tasks and exercises, where each session&#x02013;again in line with CRT&#x02013;comprises different exercises. For an overview of the exercises practiced in SAT, see Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>; for a more detailed description of the exercises, the SAT treatment manual is available upon request [<xref ref-type="bibr" rid="CR120">120</xref>].<table-wrap id="Tab3"><label>Table 3</label><caption><p>SAT exercises</p></caption><table frame="hsides" rules="groups"><tbody><tr><td>Motor tasks</td><td>Djenga<break/>Mikado<break/>Leaning Tower of Pisa<break/>Operation Game</td></tr><tr><td>Luck tasks</td><td>Game of the Goose<break/>Ludo<break/>Snakes and ladders</td></tr><tr><td>Collaboration task</td><td>Drawing a picture together</td></tr><tr><td>Picture tasks</td><td>Spot the differences<break/>Viewing a picture</td></tr><tr><td>Verbal tasks</td><td>Last letter-first letter<break/>Incomplete sentences task<break/>Poems</td></tr><tr><td>Additional tasks</td><td>Listening to music<break/>Analogies<break/>Categories</td></tr></tbody></table></table-wrap>
</p><p>From session 2 onward, patients are encouraged to engage in similar activities at home that they enjoy.</p></sec><sec id="Sec18"><title>Treatment as usual</title><p>After completion of either CRT or SAT, patients receive TAU. The content of TAU comprises all the essential elements recommended in the Dutch guidelines on eating disorders and OCD, which are closely related to the international guidelines [<xref ref-type="bibr" rid="CR121">121</xref>, <xref ref-type="bibr" rid="CR122">122</xref>].</p><p>TAU for patients with AN consists of normalization of eating behaviours (weight gain), discussion of daily problems, goals, psycho-education, and for a subgroup psychomotor therapy, art therapy, social skills training, family-therapy or cognitive behavioural therapy. Psychiatric- and/or medical consultation and pharmacotherapy is given where needed.</p><p>TAU for OCD patients comprises CBT delivered in 20 to 30 weekly or twice weekly 45&#x02013;90 min sessions in which exposure with response prevention forms a key element, consistent with the multidisciplinary guidelines for anxiety disorders (OCD chapter) [<xref ref-type="bibr" rid="CR121">121</xref>]. In line with the literature [<xref ref-type="bibr" rid="CR123">123</xref>, <xref ref-type="bibr" rid="CR124">124</xref>], the OCD protocol is flexible, i.e., patient-tailored with regard to the time spent on each component, accounting for differences in session and treatment duration. The therapy encompasses a) psychoeducation, b) cognitive therapy, c) exposure in vivo with response prevention, d) psychiatric consultation, and, in case of severe symptoms, pharmacotherapy with SSRIs, venlafaxine, clomipramine and/or atypical antipsychotics. The protocol allows for one or two sessions in which the principles of CBT are explained and one or two sessions in which an inventory is made of all anxiety/tension-provoking situations that give rise to compulsions and a construction of a list of compulsion triggers. All patients receive in- and between session exposure to anxiety-provoking thoughts and situations, coupled with prolonged response prevention tailored to their individual symptoms.</p></sec><sec id="Sec19"><title>Treatment fidelity</title><p>To ensure treatment fidelity for CRT and SAT, the best practices and recommendations from the NIH Behaviour Change Consortium [<xref ref-type="bibr" rid="CR125">125</xref>] are followed. The number, duration, and frequency of sessions, as well as patient-therapist contact times are kept the same for CRT and SAT. All patient-therapist contacts are formally scheduled to ensure fixed durations. All treatment sessions are audio- or videotaped and an external checker not involved in the trial rates treatment fidelity in a random selection of 10% of the recorded sessions. To evaluate, guide, and approve interventions, and to constrain &#x02018;therapist drift&#x02019;, all therapists are supervised by expert professionals, and have at least monthly intervision-sessions. After every session, the therapist completes a brief questionnaire to record treatment stage and components delivered. Deviations from the protocol are reported to the supervisor.</p></sec><sec id="Sec20"><title>Analyses</title><p>Baseline differences between the CRT and SAT (control) groups and between the participating centres are investigated using &#x003c7;<sup>2</sup> tests for categorical variables and ANOVAs for continuous variables. Additional exploratory analyses are conducted separately for AN and OCD.</p><p>The data for the primary AN and OCD outcome indices are analysed using linear mixed models (LMM) with the baseline value as a covariate. The mixed models analysing the general efficacy of CRT include a random term for the intercept and fixed terms for condition, time contrasts (T0&#x02013;T1, T0&#x02013;T2, T0&#x02013;T3, T1&#x02013;T2, T1&#x02013;T3), and the interactions between condition and time contrasts.</p><p>In order to investigate moderators of short- and long-term treatment response, time contrasts are created (T0&#x02013;T1, T0&#x02013;T2, T0&#x02013;T3, T1&#x02013;T2, T1&#x02013;T3) by means of dummy coding. Potential continuous moderator variables are standardized. Interactions between condition and the potential moderators are entered into the equation. All analyses on therapy effect modificators are of an exploratory nature. The moderator and mediator analyses are calculated with 5000 bootstraps [<xref ref-type="bibr" rid="CR126">126</xref>].</p><p>To assess the cost-effectiveness of CRT&#x02009;+&#x02009;TAU versus SAT&#x02009;+&#x02009;TAU for ED and OCD, all relevant costs and effects are taken into account. Disease progression is described in terms of transitions between &#x02018;states&#x02019;, where a patient&#x02019;s &#x02018;state&#x02019; can shift in either direction or remain constant. Estimations of state-transition rates are based on the data from the ongoing trial and the literature, which modelling approach serves to help us assess future scenarios. Costs and effects are calculated in accordance with recommendations in the Dutch guideline for economic evaluation of health care. As a primary assessment we apply a costs-utility analysis that yields a cost per quality-adjusted life years (QALY) outcome, a common cost-effectiveness measure that allows comparison with economic evaluations of other diseases and interventions. The uncertainty estimations are computed using bootstrapping and the results expressed in an acceptability curve. If no intervention is effective, a cost-minimization calculation is performed.</p></sec></sec><sec id="Sec21"><title>Discussion</title><p>Inefficiencies in cognitive flexibility and central coherence are problematic in psychiatric disorders. CRT aims at addressing these inefficiencies and thus enhancing treatment outcome. To our knowledge, this is the first randomized controlled trial using a control condition evaluating the efficacy and effectiveness of CRT as a treatment enhancer preceding TAU for AN, and the first study to investigate CRT in OCD, moreover taking cost-effectiveness of CRT in AN and OCD into account. This study enables us to establish whether the anticipated treatment-enhancing effect of CRT is achieved by improvement of the patients&#x02019; cognitive flexibility. With this transdiagnostic approach, we will additionally learn whether CRT challenges a diagnosis-specific problem or taps shared underlying mechanisms for AN and OCD.</p><p>Another strength of our trial is that CRT effectiveness is investigated in established clinics specialized in the treatment of patients with severe symptoms.</p><p>A potential limitation of this trial is the fact that we have not tested the validity of SAT as a control condition, i.e. a condition that lacks the potential working mechanisms of CRT . Further, the credibility of SAT as an alternative treatment to CRT has not been tested. After baseline assessment, patients are told which intervention they receive (CRT or SAT). Although they are not told that CRT is the therapy-enhancer being investigated and that SAT is offered as a control intervention, patients might be able to &#x02018;guess&#x02019; which therapy entails the control condition, potentially biasing treatment expectancy and credibility.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>ADHD</term><def><p>Attention deficit hyperactivity disorder</p></def></def-item><def-item><term>AN</term><def><p>Anorexia nervosa</p></def></def-item><def-item><term>AQ</term><def><p>Autism-spectrum quotient</p></def></def-item><def-item><term>BADS</term><def><p>Behavioural Assessment of the Dysexecutive Syndrome</p></def></def-item><def-item><term>BAI</term><def><p>Beck Anxiety Inventory</p></def></def-item><def-item><term>BDI-II</term><def><p>Beck Depression Inventory, second revision</p></def></def-item><def-item><term>BISBAS</term><def><p>Behavioural Inhibition and Behavioural Activation Scales</p></def></def-item><def-item><term>BvP</term><def><p>Boris van Passel</p></def></def-item><def-item><term>CAARS-S-SV</term><def><p>Connors&#x02019; Adult ADHD Rating Scales, Self-report, Short Version</p></def></def-item><def-item><term>CANTAB</term><def><p>Cambridge Neuropsychological Test Automated Battery</p></def></def-item><def-item><term>CBT</term><def><p>Cognitive Behaviour Therapy</p></def></def-item><def-item><term>CPQ</term><def><p>Clinical Perfectionism Questionnaire</p></def></def-item><def-item><term>CRT</term><def><p>Cognitive remediation therapy</p></def></def-item><def-item><term>DART</term><def><p>Dutch Adult Reading Test</p></def></def-item><def-item><term>DC</term><def><p>Dani&#x000eb;lle Cath</p></def></def-item><def-item><term>D-FLEX</term><def><p>Detail and Flexibility Questionnaire</p></def></def-item><def-item><term>D-KEFS</term><def><p>Delis-Kaplan Executive Function System</p></def></def-item><def-item><term>DSM-IV-TR</term><def><p>Diagnostic and Statistical Manual of Mental Disorders, fourth edition text revision</p></def></def-item><def-item><term>ED</term><def><p>Eating disorder</p></def></def-item><def-item><term>EDE-Q</term><def><p>Eating Disorder Examination Questionnaire</p></def></def-item><def-item><term>EDQoL</term><def><p>Eating Disorder Quality of Life questionnaire</p></def></def-item><def-item><term>EQ-5D</term><def><p>EuroQoL five dimensions questionnaire</p></def></def-item><def-item><term>GEFT</term><def><p>Group embedded figures test</p></def></def-item><def-item><term>IBM</term><def><p>International Business Machines</p></def></def-item><def-item><term>ID/EDS</term><def><p>Intra dimensional-/extra dimensional shift paradigm</p></def></def-item><def-item><term>iMTA</term><def><p>Institute for Medical Technology Assessment</p></def></def-item><def-item><term>IUS</term><def><p>Intolerance of Uncertainty Scale</p></def></def-item><def-item><term>LMM</term><def><p>Linear mixed models</p></def></def-item><def-item><term>LS</term><def><p>Lot Sternheim</p></def></def-item><def-item><term>METc</term><def><p>Medical Ethical Committee (in Dutch: Medisch Ethische Toetsingsingscommissie)</p></def></def-item><def-item><term>MSc</term><def><p>Master of Science</p></def></def-item><def-item><term>NART</term><def><p>National Adult Reading Test</p></def></def-item><def-item><term>NIH</term><def><p>National Institutes of Health</p></def></def-item><def-item><term>OCD</term><def><p>Obsessive-compulsive disorder</p></def></def-item><def-item><term>OCDQoL</term><def><p>Obsessive-Compulsive Disorder Quality of Life questionnaire</p></def></def-item><def-item><term>OCI-R</term><def><p>Obsessive-Compulsive Inventory-Revised</p></def></def-item><def-item><term>OCPD</term><def><p>Obsessive-compulsive personality disorder</p></def></def-item><def-item><term>PEPPI-5</term><def><p>Perceived Efficacy in Patient-Physician Interactions</p></def></def-item><def-item><term>QALY</term><def><p>Quality Adjusted Life Years</p></def></def-item><def-item><term>Qol</term><def><p>Quality of life</p></def></def-item><def-item><term>RCT</term><def><p>Randomized controlled trial</p></def></def-item><def-item><term>SAT</term><def><p>Specialized Attention Therapy</p></def></def-item><def-item><term>SCID-I</term><def><p>Structured clinical interview for DSM-IV-TR axis I disorders</p></def></def-item><def-item><term>SCID-II</term><def><p>Structured Clinical Interview for DSM-IV-TR axis II disorders</p></def></def-item><def-item><term>SPSS</term><def><p>Statistical Package for the Social Sciences</p></def></def-item><def-item><term>SRS</term><def><p>Session Rating Scale</p></def></def-item><def-item><term>SSRI</term><def><p>Selective serotonin reuptake inhibitor</p></def></def-item><def-item><term>SSRT</term><def><p>Stop Signal Reaction Task</p></def></def-item><def-item><term>TAU</term><def><p>Treatment as usual</p></def></def-item><def-item><term>TIC-p</term><def><p>Trimbos/iMTA questionnaire for Costs associated with Psychiatric illness</p></def></def-item><def-item><term>TMT</term><def><p>Trail Making Test</p></def></def-item><def-item><term>UD</term><def><p>Unna Danner</p></def></def-item><def-item><term>WSAS</term><def><p>Work and Social Adjustment Scale</p></def></def-item><def-item><term>Y-BOCS</term><def><p>Yale-Brown Obsessive Compulsive Scale</p></def></def-item></def-list></glossary><ack><title>Acknowledgements</title><p>Not applicable.</p><sec id="FPar1"><title>Funding</title><p>This study was honoured with a grant of ZonMW, project number 837001004.</p></sec><sec id="FPar2"><title>Availability of data and materials</title><p>Supporting data and materials (CRT and SAT protocols) are available to editors and peer-reviewers for the purposes of evaluating the manuscript. The collected anonymised study screening and outcome data are available to the principal investigators.</p></sec><sec id="FPar3"><title>Authors&#x02019; contributions</title><p>BvP wrote the original manuscript in intensive collaboration with GH, DC, UD, LS, AvM and AD. All authors read and approved the final manuscript.</p></sec><sec id="FPar4"><title>Competing interests</title><p>The authors report no financial or other relationships relevant to the subject of this article.</p></sec><sec id="FPar5"><title>Consent for publication</title><p>As this manuscript does not include details or images relating to individual participants consent for publication is not applicable.</p></sec><sec id="FPar6"><title>Ethics approval and consent to participate</title><p>The Medical Ethics Committee of the University Medical Centre Utrecht has approved the study (METc no. NL43751.041.13 v.03).</p><p>All participants have given written informed consent to participate in this study.</p></sec></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>American Psychiatric Association [APA]</collab></person-group><source>Diagnostic and statistical manual of mental disorders, fourth edition, text revision (DSM-IV-TR)</source><year>2000</year><publisher-loc>Washington DC</publisher-loc><publisher-name>American Psychiatric Association</publisher-name></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Godier</surname><given-names>LR</given-names></name><name><surname>Park</surname><given-names>RJ</given-names></name></person-group><article-title>Compulsivity in anorexia nervosa: A transdiagnostic concept</article-title><source>Front Psychol</source><year>2014</year><volume>5</volume><issue>778</issue><fpage>18</fpage><pub-id pub-id-type="pmid">24550854</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torresan</surname><given-names>RC</given-names></name><name><surname>Ramos-Cerqueira</surname><given-names>AT</given-names></name><name><surname>Shavitt</surname><given-names>RG</given-names></name><name><surname>do Rosario</surname><given-names>MC</given-names></name><name><surname>de Mathis</surname><given-names>MA</given-names></name><name><surname>Miguel</surname><given-names>EC</given-names></name><name><surname>Torres</surname><given-names>AR</given-names></name></person-group><article-title>Symptom dimensions, clinical course and comorbidity in men and women with obsessive-compulsive disorder</article-title><source>Psychiatry Res</source><year>2013</year><volume>209</volume><issue>2</issue><fpage>186</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1016/j.psychres.2012.12.006</pub-id><pub-id pub-id-type="pmid">23298952</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaye</surname><given-names>WH</given-names></name><name><surname>Bulik</surname><given-names>CM</given-names></name><name><surname>Thornton</surname><given-names>L</given-names></name><name><surname>Barbarich</surname><given-names>N</given-names></name><name><surname>Masters</surname><given-names>K</given-names></name></person-group><article-title>Comorbidity of anxiety disorders with anorexia and bulimia nervosa</article-title><source>Am J Psychiatry</source><year>2004</year><volume>161</volume><issue>12</issue><fpage>2215</fpage><lpage>2221</lpage><pub-id pub-id-type="doi">10.1176/appi.ajp.161.12.2215</pub-id><pub-id pub-id-type="pmid">15569892</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jordan</surname><given-names>J</given-names></name><name><surname>Joyce</surname><given-names>PR</given-names></name><name><surname>Carter</surname><given-names>FA</given-names></name><name><surname>Horn</surname><given-names>J</given-names></name><name><surname>McIntosh</surname><given-names>VV</given-names></name><name><surname>Luty</surname><given-names>SE</given-names></name><name><surname>McKenzie</surname><given-names>JM</given-names></name><name><surname>Frampton</surname><given-names>CM</given-names></name><name><surname>Mulder</surname><given-names>RT</given-names></name><name><surname>Bulik</surname><given-names>CM</given-names></name></person-group><article-title>Specific and nonspecific comorbidity in anorexia nervosa</article-title><source>Int J Eat Disord</source><year>2008</year><volume>41</volume><issue>1</issue><fpage>47</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1002/eat.20463</pub-id><pub-id pub-id-type="pmid">17868127</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cederlof</surname><given-names>M</given-names></name><name><surname>Thornton</surname><given-names>LM</given-names></name><name><surname>Baker</surname><given-names>J</given-names></name><name><surname>Lichtenstein</surname><given-names>P</given-names></name><name><surname>Larsson</surname><given-names>H</given-names></name><name><surname>Ruck</surname><given-names>C</given-names></name><name><surname>Bulik</surname><given-names>CM</given-names></name><name><surname>Mataix-Cols</surname><given-names>D</given-names></name></person-group><article-title>Etiological overlap between obsessive-compulsive disorder and anorexia nervosa: a longitudinal cohort, multigenerational family and twin study</article-title><source>World Psychiatr : Off J World Psychiatr Assoc</source><year>2015</year><volume>14</volume><issue>3</issue><fpage>333</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1002/wps.20251</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasvikis</surname><given-names>YG</given-names></name><name><surname>Tsakiris</surname><given-names>F</given-names></name><name><surname>Marks</surname><given-names>IM</given-names></name><name><surname>Basoglu</surname><given-names>M</given-names></name><name><surname>Noshirvani</surname><given-names>HF</given-names></name></person-group><article-title>Past history of anorexia nervosa in women with obsessive-compulsive disorder</article-title><source>Int J Eat Disord</source><year>1986</year><volume>5</volume><issue>6</issue><fpage>1069</fpage><lpage>1075</lpage><pub-id pub-id-type="doi">10.1002/1098-108X(198609)5:6&#x0003c;1069::AID-EAT2260050610&#x0003e;3.0.CO;2-U</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubenstein</surname><given-names>CS</given-names></name><name><surname>Pigott</surname><given-names>TA</given-names></name><name><surname>L&#x02019;Heureux</surname><given-names>F</given-names></name><name><surname>Hill</surname><given-names>JL</given-names></name><name><surname>Murphy</surname><given-names>DL</given-names></name></person-group><article-title>A preliminary investigation of the lifetime prevalence of anorexia and bulimia nervosa in patients with obsessive compulsive disorder</article-title><source>J Clin Psychiatr</source><year>1992</year><volume>53</volume><issue>9</issue><fpage>309</fpage><lpage>314</lpage></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abramovitch</surname><given-names>A</given-names></name><name><surname>Dar</surname><given-names>R</given-names></name><name><surname>Schweiger</surname><given-names>A</given-names></name><name><surname>Hermesh</surname><given-names>H</given-names></name></person-group><article-title>Neuropsychological impairments and their association with obsessive-compulsive symptom severity in obsessive-compulsive disorder</article-title><source>Arch Clin Neuropsychol</source><year>2011</year><volume>26</volume><issue>4</issue><fpage>364</fpage><lpage>376</lpage><pub-id pub-id-type="doi">10.1093/arclin/acr022</pub-id><pub-id pub-id-type="pmid">21498424</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abramovitch</surname><given-names>A</given-names></name><name><surname>Abramowitz</surname><given-names>JS</given-names></name><name><surname>Mittelman</surname><given-names>A</given-names></name></person-group><article-title>The neuropsychology of adult obsessive-compulsive disorder: a meta-analysis</article-title><source>Clin Psychol Rev</source><year>2013</year><volume>33</volume><issue>8</issue><fpage>1163</fpage><lpage>1171</lpage><pub-id pub-id-type="doi">10.1016/j.cpr.2013.09.004</pub-id><pub-id pub-id-type="pmid">24128603</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galimberti</surname><given-names>E</given-names></name><name><surname>Martoni</surname><given-names>RM</given-names></name><name><surname>Cavallini</surname><given-names>MC</given-names></name><name><surname>Erzegovesi</surname><given-names>S</given-names></name><name><surname>Bellodi</surname><given-names>L</given-names></name></person-group><article-title>Motor inhibition and cognitive flexibility in eating disorder subtypes</article-title><source>Prog Neuropsychopharmacol Biol Psychiatry</source><year>2012</year><volume>36</volume><issue>2</issue><fpage>307</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1016/j.pnpbp.2011.10.017</pub-id><pub-id pub-id-type="pmid">22079108</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snyder</surname><given-names>HR</given-names></name><name><surname>Kaiser</surname><given-names>RH</given-names></name><name><surname>Warren</surname><given-names>SL</given-names></name><name><surname>Heller</surname><given-names>W</given-names></name></person-group><article-title>Obsessive-compulsive disorder is associated with broad impairments in executive function: A meta-analysis</article-title><source>Clin Psychol Sci</source><year>2015</year><volume>3</volume><issue>2</issue><fpage>301</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1177/2167702614534210</pub-id><pub-id pub-id-type="pmid">25755918</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tchanturia</surname><given-names>K</given-names></name><name><surname>Davies</surname><given-names>H</given-names></name><name><surname>Roberts</surname><given-names>M</given-names></name><name><surname>Harrison</surname><given-names>A</given-names></name><name><surname>Nakazato</surname><given-names>M</given-names></name><name><surname>Schmidt</surname><given-names>U</given-names></name><name><surname>Treasure</surname><given-names>J</given-names></name><name><surname>Morris</surname><given-names>R</given-names></name></person-group><article-title>Poor cognitive flexibility in eating disorders: examining the evidence using the Wisconsin Card Sorting Task</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><issue>1</issue><fpage>e28331</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0028331</pub-id><pub-id pub-id-type="pmid">22253689</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tchanturia</surname><given-names>K</given-names></name><name><surname>Harrison</surname><given-names>A</given-names></name><name><surname>Davies</surname><given-names>H</given-names></name><name><surname>Roberts</surname><given-names>M</given-names></name><name><surname>Oldershaw</surname><given-names>A</given-names></name><name><surname>Nakazato</surname><given-names>M</given-names></name><name><surname>Stahl</surname><given-names>D</given-names></name><name><surname>Morris</surname><given-names>R</given-names></name><name><surname>Schmidt</surname><given-names>U</given-names></name><name><surname>Treasure</surname><given-names>J</given-names></name></person-group><article-title>Cognitive flexibility and clinical severity in eating disorders</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><issue>6</issue><fpage>e20462</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0020462</pub-id><pub-id pub-id-type="pmid">21698277</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinglass</surname><given-names>J</given-names></name><name><surname>Walsh</surname><given-names>BT</given-names></name></person-group><article-title>Habit learning and anorexia nervosa: A cognitive neuroscience hypothesis</article-title><source>Int J Eat Disord</source><year>2006</year><volume>39</volume><issue>4</issue><fpage>267</fpage><lpage>275</lpage><pub-id pub-id-type="doi">10.1002/eat.20244</pub-id><pub-id pub-id-type="pmid">16523472</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harkin</surname><given-names>B</given-names></name><name><surname>Kessler</surname><given-names>K</given-names></name></person-group><article-title>The role of working memory in compulsive checking and OCD: a systematic classification of 58 experimental findings</article-title><source>Clin Psychol Rev</source><year>2011</year><volume>31</volume><issue>6</issue><fpage>1004</fpage><lpage>1021</lpage><pub-id pub-id-type="doi">10.1016/j.cpr.2011.06.004</pub-id><pub-id pub-id-type="pmid">21741340</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chamberlain</surname><given-names>SR</given-names></name><name><surname>Fineberg</surname><given-names>NA</given-names></name><name><surname>Blackwell</surname><given-names>AD</given-names></name><name><surname>Robbins</surname><given-names>TW</given-names></name><name><surname>Sahakian</surname><given-names>BJ</given-names></name></person-group><article-title>Motor Inhibition and Cognitive Flexibility in Obsessive-Compulsive Disorder and Trichotillomania</article-title><source>Am J Psychiatry</source><year>2006</year><volume>163</volume><issue>7</issue><fpage>1282</fpage><lpage>1284</lpage><pub-id pub-id-type="doi">10.1176/ajp.2006.163.7.1282</pub-id><pub-id pub-id-type="pmid">16816237</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Treasure</surname><given-names>J</given-names></name><name><surname>Schmidt</surname><given-names>U</given-names></name></person-group><article-title>The cognitive-interpersonal maintenance model of anorexia nervosa revisited: a summary of the evidence for cognitive, socio-emotional and interpersonal predisposing and perpetuating factors</article-title><source>J Eat Disord</source><year>2013</year><volume>1</volume><fpage>13</fpage><pub-id pub-id-type="doi">10.1186/2050-2974-1-13</pub-id><pub-id pub-id-type="pmid">24999394</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chamberlain</surname><given-names>SR</given-names></name><name><surname>Fineberg</surname><given-names>NA</given-names></name><name><surname>Menzies</surname><given-names>LA</given-names></name><name><surname>Blackwell</surname><given-names>AD</given-names></name><name><surname>Bullmore</surname><given-names>ET</given-names></name><name><surname>Robbins</surname><given-names>TW</given-names></name><name><surname>Sahakian</surname><given-names>BJ</given-names></name></person-group><article-title>Impaired cognitive flexibility and motor inhibition in unaffected first-degree relatives of patients with obsessive-compulsive disorder</article-title><source>Am J Psychiatry</source><year>2007</year><volume>164</volume><issue>2</issue><fpage>335</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1176/ajp.2007.164.2.335</pub-id><pub-id pub-id-type="pmid">17267798</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segalas</surname><given-names>C</given-names></name><name><surname>Alonso</surname><given-names>P</given-names></name><name><surname>Real</surname><given-names>E</given-names></name><name><surname>Garcia</surname><given-names>A</given-names></name><name><surname>Minambres</surname><given-names>A</given-names></name><name><surname>Labad</surname><given-names>J</given-names></name><name><surname>Pertusa</surname><given-names>A</given-names></name><name><surname>Bueno</surname><given-names>B</given-names></name><name><surname>Jimenez-Murcia</surname><given-names>S</given-names></name><name><surname>Menchon</surname><given-names>JM</given-names></name></person-group><article-title>Memory and strategic processing in first-degree relatives of obsessive compulsive patients</article-title><source>Psychol Med</source><year>2010</year><volume>40</volume><issue>12</issue><fpage>2001</fpage><lpage>2011</lpage><pub-id pub-id-type="doi">10.1017/S0033291710000310</pub-id><pub-id pub-id-type="pmid">20214841</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>ME</given-names></name><name><surname>Tchanturia</surname><given-names>K</given-names></name><name><surname>Treasure</surname><given-names>JL</given-names></name></person-group><article-title>Exploring the neurocognitive signature of poor set-shifting in anorexia and bulimia nervosa</article-title><source>J Psychiatr Res</source><year>2010</year><volume>44</volume><issue>14</issue><fpage>964</fpage><lpage>970</lpage><pub-id pub-id-type="doi">10.1016/j.jpsychires.2010.03.001</pub-id><pub-id pub-id-type="pmid">20398910</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>EL</given-names></name></person-group><article-title>Evaluating the theory of executive dysfunction in autism</article-title><source>Dev Rev</source><year>2004</year><volume>24</volume><issue>2</issue><fpage>189</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1016/j.dr.2004.01.001</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chamberlain</surname><given-names>SR</given-names></name><name><surname>Menzies</surname><given-names>LA</given-names></name><name><surname>Hampshire</surname><given-names>A</given-names></name><name><surname>Suckling</surname><given-names>J</given-names></name><name><surname>Fineberg</surname><given-names>NA</given-names></name><name><surname>del Campo</surname><given-names>N</given-names></name><name><surname>Aitken</surname><given-names>M</given-names></name><name><surname>Craig</surname><given-names>K</given-names></name><name><surname>Owen</surname><given-names>AM</given-names></name><name><surname>Bullmore</surname><given-names>ET</given-names></name><etal/></person-group><article-title>Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives</article-title><source>Science</source><year>2008</year><volume>321</volume><issue>5887</issue><fpage>421</fpage><lpage>422</lpage><pub-id pub-id-type="doi">10.1126/science.1154433</pub-id><pub-id pub-id-type="pmid">18635808</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gillan</surname><given-names>CM</given-names></name><name><surname>Papmeyer</surname><given-names>M</given-names></name><name><surname>Morein-Zamir</surname><given-names>S</given-names></name><name><surname>Sahakian</surname><given-names>BJ</given-names></name><name><surname>Fineberg</surname><given-names>NA</given-names></name><name><surname>Robbins</surname><given-names>TW</given-names></name><name><surname>de Wit</surname><given-names>S</given-names></name></person-group><article-title>Disruption in the balance between goal-directed behavior and habit learning in obsessive-compulsive disorder</article-title><source>Am J Psychiatry</source><year>2011</year><volume>168</volume><issue>7</issue><fpage>718</fpage><lpage>726</lpage><pub-id pub-id-type="doi">10.1176/appi.ajp.2011.10071062</pub-id><pub-id pub-id-type="pmid">21572165</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lang</surname><given-names>K</given-names></name><name><surname>Lopez</surname><given-names>C</given-names></name><name><surname>Stahl</surname><given-names>D</given-names></name><name><surname>Tchanturia</surname><given-names>K</given-names></name><name><surname>Treasure</surname><given-names>J</given-names></name></person-group><article-title>Central coherence in eating disorders: an updated systematic review and meta-analysis</article-title><source>World J Biol Psychiatry</source><year>2014</year><volume>15</volume><issue>8</issue><fpage>586</fpage><lpage>598</lpage><pub-id pub-id-type="doi">10.3109/15622975.2014.909606</pub-id><pub-id pub-id-type="pmid">24882144</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savage</surname><given-names>CR</given-names></name><name><surname>Baer</surname><given-names>L</given-names></name><name><surname>Keuthen</surname><given-names>NJ</given-names></name><name><surname>Brown</surname><given-names>HD</given-names></name><name><surname>Rauch</surname><given-names>SL</given-names></name><name><surname>Jenike</surname><given-names>MA</given-names></name></person-group><article-title>Organizational strategies mediate nonverbal memory impairment in obsessive-compulsive disorder</article-title><source>Biol Psychiatry</source><year>1999</year><volume>45</volume><issue>7</issue><fpage>905</fpage><lpage>916</lpage><pub-id pub-id-type="doi">10.1016/S0006-3223(98)00278-9</pub-id><pub-id pub-id-type="pmid">10202579</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savage</surname><given-names>CR</given-names></name><name><surname>Deckersbach</surname><given-names>T</given-names></name><name><surname>Wilhelm</surname><given-names>S</given-names></name><name><surname>Rauch</surname><given-names>SL</given-names></name><name><surname>Baer</surname><given-names>L</given-names></name><name><surname>Reid</surname><given-names>T</given-names></name><name><surname>Jenike</surname><given-names>MA</given-names></name></person-group><article-title>Strategic processing and episodic memory impairment in obsessive compulsive disorder</article-title><source>Neuropsychology</source><year>2000</year><volume>14</volume><issue>1</issue><fpage>141</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1037/0894-4105.14.1.141</pub-id><pub-id pub-id-type="pmid">10674806</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>N</given-names></name><name><surname>Lee</surname><given-names>T</given-names></name><name><surname>Kim</surname><given-names>E</given-names></name><name><surname>Kwon</surname><given-names>J</given-names></name></person-group><article-title>Cognitive functioning in obsessive-compulsive disorder: A meta-analysis</article-title><source>Psychol Med</source><year>2014</year><volume>44</volume><issue>6</issue><fpage>1121</fpage><lpage>1130</lpage><pub-id pub-id-type="doi">10.1017/S0033291713001803</pub-id><pub-id pub-id-type="pmid">23866289</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Head</surname><given-names>D</given-names></name><name><surname>Bolton</surname><given-names>D</given-names></name><name><surname>Hymas</surname><given-names>N</given-names></name></person-group><article-title>Deficit in cognitive shifting ability in patients with obsessive-compulsive disorder</article-title><source>Biol Psychiatry</source><year>1989</year><volume>25</volume><issue>7</issue><fpage>929</fpage><lpage>937</lpage><pub-id pub-id-type="doi">10.1016/0006-3223(89)90272-2</pub-id><pub-id pub-id-type="pmid">2720006</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>American Psychiatric Association [APA]</collab></person-group><article-title>Treatment of patients with eating disorders, third edition</article-title><source>Am J Psychiatry</source><year>2006</year><volume>163</volume><issue>7 Suppl</issue><fpage>4</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">16925191</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>HJ</given-names></name><name><surname>Bulik</surname><given-names>CM</given-names></name></person-group><article-title>Update on the treatment of anorexia nervosa: review of clinical trials, practice guidelines and emerging interventions</article-title><source>Psychol Med</source><year>2013</year><volume>43</volume><issue>12</issue><fpage>2477</fpage><lpage>2500</lpage><pub-id pub-id-type="doi">10.1017/S0033291712002620</pub-id><pub-id pub-id-type="pmid">23217606</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zipfel</surname><given-names>S</given-names></name><name><surname>Wild</surname><given-names>B</given-names></name><name><surname>Gross</surname><given-names>G</given-names></name><name><surname>Friederich</surname><given-names>HC</given-names></name><name><surname>Teufel</surname><given-names>M</given-names></name><name><surname>Schellberg</surname><given-names>D</given-names></name><name><surname>Giel</surname><given-names>KE</given-names></name><name><surname>de Zwaan</surname><given-names>M</given-names></name><name><surname>Dinkel</surname><given-names>A</given-names></name><name><surname>Herpertz</surname><given-names>S</given-names></name><etal/></person-group><article-title>Focal psychodynamic therapy, cognitive behaviour therapy, and optimised treatment as usual in outpatients with anorexia nervosa (ANTOP study): randomised controlled trial</article-title><source>Lancet</source><year>2014</year><volume>383</volume><issue>9912</issue><fpage>127</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(13)61746-8</pub-id><pub-id pub-id-type="pmid">24131861</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinhausen</surname><given-names>HC</given-names></name></person-group><article-title>The outcome of anorexia nervosa in the 20th century</article-title><source>Am J Psychiatry</source><year>2002</year><volume>159</volume><issue>8</issue><fpage>1284</fpage><lpage>1293</lpage><pub-id pub-id-type="doi">10.1176/appi.ajp.159.8.1284</pub-id><pub-id pub-id-type="pmid">12153817</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danner</surname><given-names>UN</given-names></name><name><surname>Dingemans</surname><given-names>AE</given-names></name><name><surname>Steinglass</surname><given-names>J</given-names></name></person-group><article-title>Cognitive remediation therapy for eating disorders</article-title><source>Curr Opin Psychiatry</source><year>2015</year><volume>28</volume><issue>6</issue><fpage>468</fpage><lpage>472</lpage><pub-id pub-id-type="doi">10.1097/YCO.0000000000000192</pub-id><pub-id pub-id-type="pmid">26382156</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koran</surname><given-names>LM</given-names></name><name><surname>Hanna</surname><given-names>GL</given-names></name><name><surname>Hollander</surname><given-names>E</given-names></name><name><surname>Nestadt</surname><given-names>G</given-names></name><name><surname>Simpson</surname><given-names>HB</given-names></name><name><surname>American Psychiatric</surname><given-names>A</given-names></name></person-group><article-title>Practice guideline for the treatment of patients with obsessive-compulsive disorder</article-title><source>Am J Psychiatry</source><year>2007</year><volume>164</volume><issue>7 Suppl</issue><fpage>5</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">17849776</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>National Institute for Health and Clinical Excellence (Great Britain), National Collaborating Centre for Mental Health</collab></person-group><source>Obsessive-compulsive disorder : core interventions in the treatment of obsessive-compulsive disorder and body dysmorphic disorder</source><year>2005</year><publisher-loc>London</publisher-loc><publisher-name>National Institute for Health and Clinical Excellence</publisher-name></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eddy</surname><given-names>KT</given-names></name><name><surname>Dutra</surname><given-names>L</given-names></name><name><surname>Bradley</surname><given-names>R</given-names></name><name><surname>Westen</surname><given-names>D</given-names></name></person-group><article-title>A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive-compulsive disorder</article-title><source>Clin Psychol Rev</source><year>2004</year><volume>24</volume><issue>8</issue><fpage>1011</fpage><lpage>1030</lpage><pub-id pub-id-type="doi">10.1016/j.cpr.2004.08.004</pub-id><pub-id pub-id-type="pmid">15533282</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosa-Alc&#x000e1;zar</surname><given-names>AI</given-names></name><name><surname>S&#x000e1;nchez-Meca</surname><given-names>J</given-names></name><name><surname>G&#x000f3;mez-Conesa</surname><given-names>A</given-names></name><name><surname>Mar&#x000ed;n-Mart&#x000ed;nez</surname><given-names>F</given-names></name></person-group><article-title>Psychological treatment of obsessive&#x02013;compulsive disorder: A meta-analysis</article-title><source>Clin Psychol Rev</source><year>2008</year><volume>28</volume><issue>8</issue><fpage>1310</fpage><lpage>1325</lpage><pub-id pub-id-type="doi">10.1016/j.cpr.2008.07.001</pub-id><pub-id pub-id-type="pmid">18701199</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olatunji</surname><given-names>BO</given-names></name><name><surname>Davis</surname><given-names>ML</given-names></name><name><surname>Powers</surname><given-names>MB</given-names></name><name><surname>Smits</surname><given-names>JAJ</given-names></name></person-group><article-title>Cognitive-behavioral therapy for obsessive-compulsive disorder: A meta-analysis of treatment outcome and moderators</article-title><source>J Psychiatr Res</source><year>2013</year><volume>47</volume><issue>1</issue><fpage>33</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1016/j.jpsychires.2012.08.020</pub-id><pub-id pub-id-type="pmid">22999486</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>E</given-names></name><name><surname>Thennarasu</surname><given-names>K</given-names></name><name><surname>Reddy</surname><given-names>YCJ</given-names></name></person-group><article-title>Long-term outcome of obsessive-compulsive disorder in adults: A meta-analysis</article-title><source>J Clin Psychiatry</source><year>2014</year><volume>75</volume><issue>9</issue><fpage>1019</fpage><lpage>1027</lpage><pub-id pub-id-type="doi">10.4088/JCP.13r08849</pub-id><pub-id pub-id-type="pmid">25295427</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skoog</surname><given-names>G</given-names></name><name><surname>Skoog</surname><given-names>I</given-names></name></person-group><article-title>A 40-year follow-up of patients with obsessive-compulsive disorder [see commetns]</article-title><source>Arch Gen Psychiatry</source><year>1999</year><volume>56</volume><issue>2</issue><fpage>121</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1001/archpsyc.56.2.121</pub-id><pub-id pub-id-type="pmid">10025435</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloch</surname><given-names>MH</given-names></name><name><surname>Green</surname><given-names>C</given-names></name><name><surname>Kichuk</surname><given-names>SA</given-names></name><name><surname>Dombrowski</surname><given-names>PA</given-names></name><name><surname>Wasylink</surname><given-names>S</given-names></name><name><surname>Billingslea</surname><given-names>E</given-names></name><name><surname>Landeros-Weisenberger</surname><given-names>A</given-names></name><name><surname>Kelmendi</surname><given-names>B</given-names></name><name><surname>Goodman</surname><given-names>WK</given-names></name><name><surname>Leckman</surname><given-names>JF</given-names></name><etal/></person-group><article-title>Long-term outcome in adults with obsessive-compulsive disorder</article-title><source>Depress Anxiety</source><year>2013</year><volume>30</volume><issue>8</issue><fpage>716</fpage><lpage>722</lpage><pub-id pub-id-type="doi">10.1002/da.22103</pub-id><pub-id pub-id-type="pmid">23532944</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aderka</surname><given-names>IM</given-names></name><name><surname>Anholt</surname><given-names>GE</given-names></name><name><surname>van Balkom</surname><given-names>AJ</given-names></name><name><surname>Smit</surname><given-names>JH</given-names></name><name><surname>Hermesh</surname><given-names>H</given-names></name><name><surname>Hofmann</surname><given-names>SG</given-names></name><name><surname>van Oppen</surname><given-names>P</given-names></name></person-group><article-title>Differences between early and late drop-outs from treatment for obsessive-compulsive disorder</article-title><source>J Anxiety Disord</source><year>2011</year><volume>25</volume><issue>7</issue><fpage>918</fpage><lpage>923</lpage><pub-id pub-id-type="doi">10.1016/j.janxdis.2011.05.004</pub-id><pub-id pub-id-type="pmid">21664103</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foa</surname><given-names>EB</given-names></name><name><surname>Liebowitz</surname><given-names>MR</given-names></name><name><surname>Kozak</surname><given-names>MJ</given-names></name><name><surname>Davies</surname><given-names>S</given-names></name><name><surname>Campeas</surname><given-names>R</given-names></name><name><surname>Franklin</surname><given-names>ME</given-names></name><name><surname>Huppert</surname><given-names>JD</given-names></name><name><surname>Kjernisted</surname><given-names>K</given-names></name><name><surname>Rowan</surname><given-names>V</given-names></name><name><surname>Schmidt</surname><given-names>AB</given-names></name><etal/></person-group><article-title>Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder</article-title><source>Am J Psychiatry</source><year>2005</year><volume>162</volume><issue>1</issue><fpage>151</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1176/appi.ajp.162.1.151</pub-id><pub-id pub-id-type="pmid">15625214</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobak</surname><given-names>KA</given-names></name><name><surname>Greist</surname><given-names>JH</given-names></name><name><surname>Jefferson</surname><given-names>JW</given-names></name><name><surname>Katzelnick</surname><given-names>DJ</given-names></name><name><surname>Henk</surname><given-names>HJ</given-names></name></person-group><article-title>Behavioral versus pharmacological treatments of obsessive compulsive disorder: a meta-analysis</article-title><source>Psychopharmacology</source><year>1998</year><volume>136</volume><issue>3</issue><fpage>205</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1007/s002130050558</pub-id><pub-id pub-id-type="pmid">9566805</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>S</given-names></name><name><surname>Thordarson</surname><given-names>DS</given-names></name><name><surname>Spring</surname><given-names>T</given-names></name><name><surname>Yeh</surname><given-names>AH</given-names></name><name><surname>Corcoran</surname><given-names>KM</given-names></name><name><surname>Eugster</surname><given-names>K</given-names></name><name><surname>Tisshaw</surname><given-names>C</given-names></name></person-group><article-title>Telephone-administered cognitive behavior therapy for obsessive-compulsive disorder</article-title><source>Cogn Behav Ther</source><year>2003</year><volume>32</volume><issue>1</issue><fpage>13</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1080/16506070310003639</pub-id><pub-id pub-id-type="pmid">16291531</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abramowitz</surname><given-names>JS</given-names></name></person-group><article-title>Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: a quantitative review</article-title><source>J Consult Clin Psychol</source><year>1997</year><volume>65</volume><issue>1</issue><fpage>44</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1037/0022-006X.65.1.44</pub-id><pub-id pub-id-type="pmid">9103733</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dejong</surname><given-names>H</given-names></name><name><surname>Broadbent</surname><given-names>H</given-names></name><name><surname>Schmidt</surname><given-names>U</given-names></name></person-group><article-title>A systematic review of dropout from treatment in outpatients with anorexia nervosa</article-title><source>Int J Eat Disord</source><year>2012</year><volume>45</volume><issue>5</issue><fpage>635</fpage><lpage>647</lpage><pub-id pub-id-type="doi">10.1002/eat.20956</pub-id><pub-id pub-id-type="pmid">22684990</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>H</given-names></name><name><surname>Tchanturia</surname><given-names>K</given-names></name></person-group><article-title>Cognitive remediation therapy as an intervention for acute anorexia nervosa: a case report</article-title><source>Eur Eat Disord Rev</source><year>2005</year><volume>13</volume><issue>5</issue><fpage>311</fpage><lpage>316</lpage><pub-id pub-id-type="doi">10.1002/erv.655</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><mixed-citation publication-type="other">Tchanturia K. Cognitive remediation therapy (CRT) for eating and weight disorders. London: Routledge; 2015.</mixed-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevenson</surname><given-names>CS</given-names></name><name><surname>Whitmont</surname><given-names>S</given-names></name><name><surname>Bornholt</surname><given-names>L</given-names></name><name><surname>Livesey</surname><given-names>D</given-names></name><name><surname>Stevenson</surname><given-names>RJ</given-names></name></person-group><article-title>A cognitive remediation programme for adults with Attention Deficit Hyperactivity Disorder</article-title><source>Aust N Z J Psychiatry</source><year>2002</year><volume>36</volume><issue>5</issue><fpage>610</fpage><lpage>616</lpage><pub-id pub-id-type="doi">10.1046/j.1440-1614.2002.01052.x</pub-id><pub-id pub-id-type="pmid">12225443</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wykes</surname><given-names>T</given-names></name><name><surname>Huddy</surname><given-names>V</given-names></name><name><surname>Cellard</surname><given-names>C</given-names></name><name><surname>McGurk</surname><given-names>SR</given-names></name><name><surname>Czobor</surname><given-names>P</given-names></name></person-group><article-title>A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes</article-title><source>Am J Psychiatry</source><year>2011</year><volume>168</volume><issue>5</issue><fpage>472</fpage><lpage>485</lpage><pub-id pub-id-type="doi">10.1176/appi.ajp.2010.10060855</pub-id><pub-id pub-id-type="pmid">21406461</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><mixed-citation publication-type="other">Saperstein AM, Medalia A. The role of motivation in cognitive remediation for people with schizophrenia. Curr Top Behav Neurosci. 2016;27:533-46.</mixed-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindvall Dahlgren</surname><given-names>C</given-names></name><name><surname>R&#x000f8;</surname><given-names>&#x000d8;</given-names></name></person-group><article-title>A systematic review of cognitive remediation therapy for anorexia nervosa - development, current state and implications for future research and clinical practice</article-title><source>J Eat Disord</source><year>2014</year><volume>2</volume><issue>1</issue><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1186/2050-2974-2-1</pub-id><pub-id pub-id-type="pmid">24999424</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lock</surname><given-names>J</given-names></name><name><surname>Agras</surname><given-names>WS</given-names></name><name><surname>Fitzpatrick</surname><given-names>KK</given-names></name><name><surname>Bryson</surname><given-names>SW</given-names></name><name><surname>Jo</surname><given-names>B</given-names></name><name><surname>Tchanturia</surname><given-names>K</given-names></name></person-group><article-title>Is outpatient cognitive remediation therapy feasible to use in randomized clinical trials for anorexia nervosa?</article-title><source>Int J Eat Disord</source><year>2013</year><volume>46</volume><issue>6</issue><fpage>567</fpage><lpage>575</lpage><pub-id pub-id-type="doi">10.1002/eat.22134</pub-id><pub-id pub-id-type="pmid">23625628</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brockmeyer</surname><given-names>T</given-names></name><name><surname>Ingenerf</surname><given-names>K</given-names></name><name><surname>Walther</surname><given-names>S</given-names></name><name><surname>Wild</surname><given-names>B</given-names></name><name><surname>Hartmann</surname><given-names>M</given-names></name><name><surname>Herzog</surname><given-names>W</given-names></name><name><surname>Bents</surname><given-names>H</given-names></name><name><surname>Friederich</surname><given-names>HC</given-names></name></person-group><article-title>Training cognitive flexibility in patients with anorexia nervosa: a pilot randomized controlled trial of cognitive remediation therapy</article-title><source>Int J Eat Disord</source><year>2014</year><volume>47</volume><issue>1</issue><fpage>24</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1002/eat.22206</pub-id><pub-id pub-id-type="pmid">24166941</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dingemans</surname><given-names>AE</given-names></name><name><surname>Danner</surname><given-names>UN</given-names></name><name><surname>Donker</surname><given-names>JM</given-names></name><name><surname>Aardoom</surname><given-names>JJ</given-names></name><name><surname>van Meer</surname><given-names>F</given-names></name><name><surname>Tobias</surname><given-names>K</given-names></name><name><surname>van Elburg</surname><given-names>AA</given-names></name><name><surname>van Furth</surname><given-names>EF</given-names></name></person-group><article-title>The effectiveness of cognitive remediation therapy in patients with a severe or enduring eating disorder: a randomized controlled trial</article-title><source>Psychother Psychosom</source><year>2014</year><volume>83</volume><issue>1</issue><fpage>29</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1159/000355240</pub-id><pub-id pub-id-type="pmid">24281361</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buhlmann</surname><given-names>U</given-names></name><name><surname>Deckersbach</surname><given-names>T</given-names></name><name><surname>Engelhard</surname><given-names>I</given-names></name><name><surname>Cook</surname><given-names>LM</given-names></name><name><surname>Rauch</surname><given-names>SL</given-names></name><name><surname>Kathmann</surname><given-names>N</given-names></name><name><surname>Wilhelm</surname><given-names>S</given-names></name><name><surname>Savage</surname><given-names>CR</given-names></name></person-group><article-title>Cognitive retraining for organizational impairment in obsessive-compulsive disorder</article-title><source>Psychiatry Res</source><year>2006</year><volume>144</volume><issue>2&#x02013;3</issue><fpage>109</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1016/j.psychres.2005.10.012</pub-id><pub-id pub-id-type="pmid">17007938</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>HS</given-names></name><name><surname>Shin</surname><given-names>YW</given-names></name><name><surname>Ha</surname><given-names>TH</given-names></name><name><surname>Shin</surname><given-names>MS</given-names></name><name><surname>Kim</surname><given-names>YY</given-names></name><name><surname>Lee</surname><given-names>YH</given-names></name><name><surname>Kwon</surname><given-names>JS</given-names></name></person-group><article-title>Effect of cognitive training focusing on organizational strategies in patients with obsessive-compulsive disorder</article-title><source>Psychiatry Clin Neurosci</source><year>2006</year><volume>60</volume><issue>6</issue><fpage>718</fpage><lpage>726</lpage><pub-id pub-id-type="doi">10.1111/j.1440-1819.2006.01587.x</pub-id><pub-id pub-id-type="pmid">17109706</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>AW</given-names></name><name><surname>Tetzlaff</surname><given-names>JM</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name><name><surname>Laupacis</surname><given-names>A</given-names></name><name><surname>Gotzsche</surname><given-names>PC</given-names></name><name><surname>Krleza-Jeric</surname><given-names>K</given-names></name><name><surname>Hrobjartsson</surname><given-names>A</given-names></name><name><surname>Mann</surname><given-names>H</given-names></name><name><surname>Dickersin</surname><given-names>K</given-names></name><name><surname>Berlin</surname><given-names>JA</given-names></name><etal/></person-group><article-title>SPIRIT 2013 statement: defining standard protocol items for clinical trials</article-title><source>Ann Intern Med</source><year>2013</year><volume>158</volume><issue>3</issue><fpage>200</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-158-3-201302050-00583</pub-id><pub-id pub-id-type="pmid">23295957</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Schmand</surname><given-names>B</given-names></name><name><surname>Lindeboom</surname><given-names>J</given-names></name><name><surname>Van Harskamp</surname><given-names>F</given-names></name></person-group><source>De nederlandse leestest voor volwassenen. [the dutch adult reading test]</source><year>1992</year><publisher-loc>Lisse</publisher-loc><publisher-name>Swets &#x00026; Zeitlinger</publisher-name></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>HE</given-names></name></person-group><source>The Revised National Adult Reading Test Manual</source><year>1991</year><publisher-loc>Windsor</publisher-loc><publisher-name>NFER-Nelson</publisher-name></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barker</surname><given-names>MJ</given-names></name><name><surname>Greenwood</surname><given-names>KM</given-names></name><name><surname>Jackson</surname><given-names>M</given-names></name><name><surname>Crowe</surname><given-names>SF</given-names></name></person-group><article-title>Cognitive effects of long-term benzodiazepine use: a meta-analysis</article-title><source>CNS Drugs</source><year>2004</year><volume>18</volume><issue>1</issue><fpage>37</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.2165/00023210-200418010-00004</pub-id><pub-id pub-id-type="pmid">14731058</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>First</surname><given-names>MB</given-names></name></person-group><source>User&#x02019;s guide for the structured clinical interview for DSM-IV-TR axis I disorders : SCID-I</source><year>2002</year><edition>Research</edition><publisher-loc>New York</publisher-loc><publisher-name>Biometrics Research Dept., New York State Psychiatric Institute</publisher-name></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodman</surname><given-names>WK</given-names></name><name><surname>Price</surname><given-names>LH</given-names></name><name><surname>Rasmussen</surname><given-names>SA</given-names></name><name><surname>Mazure</surname><given-names>C</given-names></name><name><surname>Delgado</surname><given-names>P</given-names></name><name><surname>Heninger</surname><given-names>GR</given-names></name><name><surname>Charney</surname><given-names>DS</given-names></name></person-group><article-title>The Yale-Brown Obsessive Compulsive Scale. II. Validity</article-title><source>Arch Gen Psychiatry</source><year>1989</year><volume>46</volume><issue>11</issue><fpage>1012</fpage><lpage>1016</lpage><pub-id pub-id-type="doi">10.1001/archpsyc.1989.01810110054008</pub-id><pub-id pub-id-type="pmid">2510699</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodman</surname><given-names>WK</given-names></name><name><surname>Price</surname><given-names>LH</given-names></name><name><surname>Rasmussen</surname><given-names>SA</given-names></name><name><surname>Mazure</surname><given-names>C</given-names></name><name><surname>Fleischmann</surname><given-names>RL</given-names></name><name><surname>Hill</surname><given-names>CL</given-names></name><name><surname>Heninger</surname><given-names>GR</given-names></name><name><surname>Charney</surname><given-names>DS</given-names></name></person-group><article-title>The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability</article-title><source>Arch Gen Psychiatry</source><year>1989</year><volume>46</volume><issue>11</issue><fpage>1006</fpage><lpage>1011</lpage><pub-id pub-id-type="doi">10.1001/archpsyc.1989.01810110048007</pub-id><pub-id pub-id-type="pmid">2684084</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><mixed-citation publication-type="other">IBM Corp. IBM SPSS Statistics for Windows, Version 23.0. Armonk: IBM Corp; Released 2015.</mixed-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>First</surname><given-names>MB</given-names></name><name><surname>Gibbon</surname><given-names>M</given-names></name><name><surname>Spitzer</surname><given-names>RL</given-names></name><name><surname>Williams</surname><given-names>JBW</given-names></name><name><surname>Benjamin</surname><given-names>LS</given-names></name></person-group><source>Structured Clinical Interview for DSM-IV Axis II Personality Disorders, (SCID-II)</source><year>1997</year><publisher-loc>Washington, D.C</publisher-loc><publisher-name>American Psychiatric Press, Inc</publisher-name></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lobbestael</surname><given-names>J</given-names></name><name><surname>Leurgans</surname><given-names>M</given-names></name><name><surname>Arntz</surname><given-names>A</given-names></name></person-group><article-title>Inter-rater reliability of the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID I) and Axis II Disorders (SCID II)</article-title><source>Clin Psychol Psychother</source><year>2011</year><volume>18</volume><issue>1</issue><fpage>75</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1002/cpp.693</pub-id><pub-id pub-id-type="pmid">20309842</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fairburn</surname><given-names>CG</given-names></name><name><surname>Beglin</surname><given-names>SJ</given-names></name></person-group><article-title>Assessment of eating disorders: Interview or self-report questionnaire?</article-title><source>Int J Eat Disord</source><year>1994</year><volume>16</volume><issue>4</issue><fpage>363</fpage><lpage>370</lpage><pub-id pub-id-type="pmid">7866415</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aardoom</surname><given-names>JJ</given-names></name><name><surname>Dingemans</surname><given-names>AE</given-names></name><name><surname>Slof Op&#x02019;t Landt</surname><given-names>MC</given-names></name><name><surname>Van Furth</surname><given-names>EF</given-names></name></person-group><article-title>Norms and discriminative validity of the Eating Disorder Examination Questionnaire (EDE-Q)</article-title><source>Eat Behav</source><year>2012</year><volume>13</volume><issue>4</issue><fpage>305</fpage><lpage>309</lpage><pub-id pub-id-type="doi">10.1016/j.eatbeh.2012.09.002</pub-id><pub-id pub-id-type="pmid">23121779</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>Z</given-names></name><name><surname>Cooper</surname><given-names>PJ</given-names></name><name><surname>Fairburn</surname><given-names>CG</given-names></name></person-group><article-title>The validity of the eating disorder examination and its subscales</article-title><source>Br J Psychiatry</source><year>1989</year><volume>154</volume><fpage>807</fpage><lpage>812</lpage><pub-id pub-id-type="doi">10.1192/bjp.154.6.807</pub-id><pub-id pub-id-type="pmid">2597887</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luce</surname><given-names>KH</given-names></name><name><surname>Crowther</surname><given-names>JH</given-names></name></person-group><article-title>The reliability of the Eating Disorder Examination-Self-Report Questionnaire Version (EDE-Q)</article-title><source>Int J Eat Disord</source><year>1999</year><volume>25</volume><issue>3</issue><fpage>349</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1098-108X(199904)25:3&#x0003c;349::AID-EAT15&#x0003e;3.0.CO;2-M</pub-id><pub-id pub-id-type="pmid">10192002</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodman</surname><given-names>WK</given-names></name><name><surname>Rasmussen</surname><given-names>SA</given-names></name><name><surname>Price</surname><given-names>LH</given-names></name><name><surname>Mazure</surname><given-names>C</given-names></name><name><surname>Heninger</surname><given-names>G</given-names></name><name><surname>Charney</surname><given-names>D</given-names></name></person-group><article-title>Yale-Brown Obsessive Compulsive Scale (Y-BOCS)</article-title><source>Verhaltenstherapie</source><year>1991</year><volume>1</volume><issue>3</issue><fpage>226</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1159/000257973</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foa</surname><given-names>EB</given-names></name><name><surname>Huppert</surname><given-names>JD</given-names></name><name><surname>Leiberg</surname><given-names>S</given-names></name><name><surname>Langner</surname><given-names>R</given-names></name><name><surname>Kichic</surname><given-names>R</given-names></name><name><surname>Hajcak</surname><given-names>G</given-names></name><name><surname>Salkovskis</surname><given-names>PM</given-names></name></person-group><article-title>The Obsessive-Compulsive Inventory: Development and validation of a short version</article-title><source>Psychol Assess</source><year>2002</year><volume>14</volume><issue>4</issue><fpage>485</fpage><lpage>496</lpage><pub-id pub-id-type="doi">10.1037/1040-3590.14.4.485</pub-id><pub-id pub-id-type="pmid">12501574</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>EuroQol</surname><given-names>G</given-names></name></person-group><article-title>EuroQol&#x02014;a new facility for the measurement of health-related quality of life</article-title><source>Health Policy</source><year>1990</year><volume>16</volume><issue>3</issue><fpage>199</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1016/0168-8510(90)90421-9</pub-id><pub-id pub-id-type="pmid">10109801</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engel</surname><given-names>SG</given-names></name><name><surname>Wittrock</surname><given-names>DA</given-names></name><name><surname>Crosby</surname><given-names>RD</given-names></name><name><surname>Wonderlich</surname><given-names>SA</given-names></name><name><surname>Mitchell</surname><given-names>JE</given-names></name><name><surname>Kolotkin</surname><given-names>RL</given-names></name></person-group><article-title>Development and psychometric validation of an eating disorder-specific health-related quality of life instrument</article-title><source>Int J Eat Disord</source><year>2006</year><volume>39</volume><issue>1</issue><fpage>62</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1002/eat.20200</pub-id><pub-id pub-id-type="pmid">16345055</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><mixed-citation publication-type="other">Cath DP, van Passel B. Obsessive-Compulsive Quality of life questionnaire. Utrecht: Utrecht University; 2013.</mixed-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mundt</surname><given-names>JC</given-names></name><name><surname>Marks</surname><given-names>IM</given-names></name><name><surname>Shear</surname><given-names>MK</given-names></name><name><surname>Greist</surname><given-names>JH</given-names></name></person-group><article-title>The Work and Social Adjustment Scale: a simple measure of impairment in functioning</article-title><source>Br J Psychiatry</source><year>2002</year><volume>180</volume><fpage>461</fpage><lpage>464</lpage><pub-id pub-id-type="doi">10.1192/bjp.180.5.461</pub-id><pub-id pub-id-type="pmid">11983645</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><mixed-citation publication-type="other">Hakkaart-van Roijen L, Van Straten A, Donker M, Trimbos/iMTA questionnaire for Costs associated with Psychiatric Illness (TiC-P) Rotterdam: iMTA; 2002. report number 02.61.</mixed-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>AT</given-names></name><name><surname>Epstein</surname><given-names>N</given-names></name><name><surname>Brown</surname><given-names>G</given-names></name><name><surname>Steer</surname><given-names>RA</given-names></name></person-group><article-title>An inventory for measuring clinical anxiety: psychometric properties</article-title><source>J Consult Clin Psychol</source><year>1988</year><volume>56</volume><issue>6</issue><fpage>893</fpage><lpage>897</lpage><pub-id pub-id-type="doi">10.1037/0022-006X.56.6.893</pub-id><pub-id pub-id-type="pmid">3204199</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>A</given-names></name><name><surname>Ward</surname><given-names>C</given-names></name><name><surname>Mendelson</surname><given-names>M</given-names></name><name><surname>Mock</surname><given-names>J</given-names></name><name><surname>Erbaugh</surname><given-names>J</given-names></name></person-group><article-title>An inventory for measuring depression</article-title><source>Arch Gen Psychiatry</source><year>1961</year><volume>4</volume><fpage>561</fpage><lpage>571</lpage><pub-id pub-id-type="doi">10.1001/archpsyc.1961.01710120031004</pub-id><pub-id pub-id-type="pmid">13688369</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abramowitz</surname><given-names>JS</given-names></name><name><surname>Deacon</surname><given-names>BJ</given-names></name></person-group><article-title>Psychometric properties and construct validity of the Obsessive-Compulsive Inventory&#x02014;Revised: Replication and extension with a clinical sample</article-title><source>J Anxiety Disord</source><year>2006</year><volume>20</volume><issue>8</issue><fpage>1016</fpage><lpage>1035</lpage><pub-id pub-id-type="doi">10.1016/j.janxdis.2006.03.001</pub-id><pub-id pub-id-type="pmid">16621437</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huppert</surname><given-names>JD</given-names></name><name><surname>Walther</surname><given-names>MR</given-names></name><name><surname>Hajcak</surname><given-names>G</given-names></name><name><surname>Yadin</surname><given-names>E</given-names></name><name><surname>Foa</surname><given-names>EB</given-names></name><name><surname>Simpson</surname><given-names>HB</given-names></name><name><surname>Liebowitz</surname><given-names>MR</given-names></name></person-group><article-title>The OCI-R: validation of the subscales in a clinical sample</article-title><source>J Anxiety Disord</source><year>2007</year><volume>21</volume><issue>3</issue><fpage>394</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1016/j.janxdis.2006.05.006</pub-id><pub-id pub-id-type="pmid">16814981</pub-id></element-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abramowitz</surname><given-names>J</given-names></name><name><surname>Tolin</surname><given-names>D</given-names></name><name><surname>Diefenbach</surname><given-names>G</given-names></name></person-group><article-title>Measuring Change in OCD: Sensitivity of the Obsessive-Compulsive Inventory-Revised</article-title><source>J Psychopathol Behav Assess</source><year>2005</year><volume>27</volume><issue>4</issue><fpage>317</fpage><lpage>324</lpage><pub-id pub-id-type="doi">10.1007/s10862-005-2411-y</pub-id></element-citation></ref><ref id="CR86"><label>86.</label><mixed-citation publication-type="other">Hakkaart- van Roijen L, Tan SS, Bouwmans CAM. Handleiding voor kostenonderzoek. Methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg Geactualiseerde versie 2010. Diemen: CVZ; 2010.</mixed-citation></ref><ref id="CR87"><label>87.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>AT</given-names></name><name><surname>Steer</surname><given-names>RA</given-names></name><name><surname>Brown</surname><given-names>GK</given-names></name></person-group><source>Manual for the Beck Depression Inventory&#x02013;II</source><year>1996</year><publisher-loc>San Antonio</publisher-loc><publisher-name>Psychological Corporation</publisher-name></element-citation></ref><ref id="CR88"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>AT</given-names></name><name><surname>Steer</surname><given-names>RA</given-names></name><name><surname>Ball</surname><given-names>R</given-names></name><name><surname>Ranieri</surname><given-names>W</given-names></name></person-group><article-title>Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients</article-title><source>J Pers Assess</source><year>1996</year><volume>67</volume><issue>3</issue><fpage>588</fpage><lpage>597</lpage><pub-id pub-id-type="doi">10.1207/s15327752jpa6703_13</pub-id><pub-id pub-id-type="pmid">8991972</pub-id></element-citation></ref><ref id="CR89"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stroop</surname><given-names>JR</given-names></name></person-group><article-title>Studies of the interference in serial verbal reactions</article-title><source>J Exp Psychol</source><year>1935</year><volume>18</volume><fpage>643</fpage><lpage>662</lpage><pub-id pub-id-type="doi">10.1037/h0054651</pub-id></element-citation></ref><ref id="CR90"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>ME</given-names></name><name><surname>Barthel</surname><given-names>FM</given-names></name><name><surname>Lopez</surname><given-names>C</given-names></name><name><surname>Tchanturia</surname><given-names>K</given-names></name><name><surname>Treasure</surname><given-names>JL</given-names></name></person-group><article-title>Development and validation of the Detail and Flexibility Questionnaire (DFlex) in eating disorders</article-title><source>Eat Behav</source><year>2011</year><volume>12</volume><issue>3</issue><fpage>168</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.1016/j.eatbeh.2011.04.001</pub-id><pub-id pub-id-type="pmid">21741013</pub-id></element-citation></ref><ref id="CR91"><label>91.</label><mixed-citation publication-type="other">Reitan R. Trail Making test: Manual for administration, scoring, and interpretation. In: University I, editor. Bloomington; 1956.</mixed-citation></ref><ref id="CR92"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lappin</surname><given-names>JS</given-names></name><name><surname>Eriksen</surname><given-names>CW</given-names></name></person-group><article-title>Use of a delayed signal to stop a visual reaction-time response</article-title><source>J Exp Psychol</source><year>1966</year><volume>72</volume><issue>6</issue><fpage>805</fpage><lpage>811</lpage><pub-id pub-id-type="doi">10.1037/h0021266</pub-id></element-citation></ref><ref id="CR93"><label>93.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Witkin</surname><given-names>H</given-names></name><name><surname>Oltman</surname><given-names>PK</given-names></name><name><surname>Raskin</surname><given-names>E</given-names></name><name><surname>Karp</surname><given-names>SA</given-names></name></person-group><source>A Manual for the Embedded Figure Test</source><year>1971</year><publisher-loc>Menlo Park</publisher-loc><publisher-name>Consulting Psychologists Press</publisher-name></element-citation></ref><ref id="CR94"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freeston</surname><given-names>MH</given-names></name><name><surname>Rheaume</surname><given-names>J</given-names></name><name><surname>Letarte</surname><given-names>H</given-names></name><name><surname>Dugas</surname><given-names>MJ</given-names></name><name><surname>Ladouceur</surname><given-names>R</given-names></name></person-group><article-title>Why do people worry?</article-title><source>Personal Individ Differ</source><year>1994</year><volume>17</volume><issue>6</issue><fpage>791</fpage><lpage>802</lpage><pub-id pub-id-type="doi">10.1016/0191-8869(94)90048-5</pub-id></element-citation></ref><ref id="CR95"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dickie</surname><given-names>L</given-names></name><name><surname>Surgenor</surname><given-names>LJ</given-names></name><name><surname>Wilson</surname><given-names>M</given-names></name><name><surname>McDowall</surname><given-names>J</given-names></name></person-group><article-title>The structure and reliability of the Clinical Perfectionism Questionnaire</article-title><source>Personal Individ Differ</source><year>2012</year><volume>52</volume><issue>8</issue><fpage>865</fpage><lpage>869</lpage><pub-id pub-id-type="doi">10.1016/j.paid.2012.02.003</pub-id></element-citation></ref><ref id="CR96"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maly</surname><given-names>RC</given-names></name><name><surname>Frank</surname><given-names>JC</given-names></name><name><surname>Marshall</surname><given-names>GN</given-names></name><name><surname>DiMatteo</surname><given-names>MR</given-names></name><name><surname>Reuben</surname><given-names>DB</given-names></name></person-group><article-title>Perceived efficacy in patient-physician interactions (PEPPI): validation of an instrument in older persons</article-title><source>J Am Geriatr Soc</source><year>1998</year><volume>46</volume><issue>7</issue><fpage>889</fpage><lpage>894</lpage><pub-id pub-id-type="doi">10.1111/j.1532-5415.1998.tb02725.x</pub-id><pub-id pub-id-type="pmid">9670878</pub-id></element-citation></ref><ref id="CR97"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carver</surname><given-names>CS</given-names></name><name><surname>White</surname><given-names>TL</given-names></name></person-group><article-title>Behavioral inhibition, behavioral activation, and affective responses to impending reward and punishment: The BIS/BAS Scales</article-title><source>J Pers Soc Psychol</source><year>1994</year><volume>67</volume><issue>2</issue><fpage>319</fpage><lpage>333</lpage><pub-id pub-id-type="doi">10.1037/0022-3514.67.2.319</pub-id></element-citation></ref><ref id="CR98"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duncan</surname><given-names>BLM</given-names></name><name><surname>Miller</surname><given-names>SD</given-names></name><name><surname>Sparks</surname><given-names>JA</given-names></name><name><surname>Claud</surname><given-names>DA</given-names></name><name><surname>Reynolds</surname><given-names>LR</given-names></name><name><surname>Brown</surname><given-names>J</given-names></name><name><surname>Johnson</surname><given-names>LD</given-names></name></person-group><article-title>The session rating scale: preliminary psychometric properties of a &#x0201c;working&#x0201d; alliance measure</article-title><source>J Brief Ther</source><year>2003</year><volume>3</volume><fpage>3</fpage><lpage>12</lpage></element-citation></ref><ref id="CR99"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dikmen</surname><given-names>SS</given-names></name><name><surname>Heaton</surname><given-names>RK</given-names></name><name><surname>Grant</surname><given-names>I</given-names></name><name><surname>Temkin</surname><given-names>NR</given-names></name></person-group><article-title>Test-retest reliability and practice effects of expanded Halstead-Reitan Neuropsychological Test Battery</article-title><source>J Int Neuropsychol Soc</source><year>1999</year><volume>5</volume><issue>4</issue><fpage>346</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1017/S1355617799544056</pub-id><pub-id pub-id-type="pmid">10349297</pub-id></element-citation></ref><ref id="CR100"><label>100.</label><mixed-citation publication-type="other">Delis DC, Delis-Kaplan KE, Kramer JH. Executive Function System (D-KEFS). In: Pearson N. San Antonio; 2001.</mixed-citation></ref><ref id="CR101"><label>101.</label><mixed-citation publication-type="other">Witkin H, Oltman P, Raskin E, Karp S. A Manual for the Embedded Figures Test. Palo Alto. Consulting Psychologists Press; 1971.</mixed-citation></ref><ref id="CR102"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruin</surname><given-names>GO</given-names></name><name><surname>Rassin</surname><given-names>EGC</given-names></name><name><surname>Heiden</surname><given-names>C</given-names></name><name><surname>Muris</surname><given-names>P</given-names></name></person-group><article-title>Psychometric properties of a Dutch version of the Intolerance of Uncertainty Scale</article-title><source>Neth J Psychol</source><year>2006</year><volume>62</volume><fpage>91</fpage><lpage>97</lpage></element-citation></ref><ref id="CR103"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helsen</surname><given-names>K</given-names></name><name><surname>Van den Bussche</surname><given-names>E</given-names></name><name><surname>Vlaeyen</surname><given-names>JWS</given-names></name><name><surname>Goubert</surname><given-names>L</given-names></name></person-group><article-title>Confirmatory factor analysis of the Dutch Intolerance of Uncertainty Scale: Comparison of the full and short version</article-title><source>J Behav Ther Exp Psychiatry</source><year>2013</year><volume>44</volume><issue>1</issue><fpage>21</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/j.jbtep.2012.07.004</pub-id><pub-id pub-id-type="pmid">22842528</pub-id></element-citation></ref><ref id="CR104"><label>104.</label><mixed-citation publication-type="other">Egan SJ, Shafran R, Lee M, Fairburn CG, Cooper Z, Doll HA, Palmer RL, Watson HJ. The reliability and validity of the clinical perfectionism questionnaire in eating disorder and community samples. Behav Cogn Psychother. 2015. No Pagination Specified.</mixed-citation></ref><ref id="CR105"><label>105.</label><mixed-citation publication-type="other">ten Klooster PM, Oostveen JC, Zandbelt LC, Taal E, Drossaert CH, Harmsen EJ, van de Laar MA. Further validation of the 5-item Perceived Efficacy in Patient-Physician Interactions (PEPPI-5) scale in patients with osteoarthritis. Patient Educ Couns. 2012;87(1):125&#x02013;130.</mixed-citation></ref><ref id="CR106"><label>106.</label><mixed-citation publication-type="other">Janse P, Boezen-Hilberdink L, van Dijk MK, Verbraak MJPM, Hutschemaekers GJM: Measuring feedback from clients. Euro J Psychol Assess. 2014;30(2):86-92.</mixed-citation></ref><ref id="CR107"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baron-Cohen</surname><given-names>S</given-names></name><name><surname>Wheelwright</surname><given-names>S</given-names></name><name><surname>Skinner</surname><given-names>R</given-names></name><name><surname>Martin</surname><given-names>J</given-names></name><name><surname>Clubley</surname><given-names>E</given-names></name></person-group><article-title>The Autism-Spectrum Quotient (AQ): Evidence from Asperger syndrome/high-functioning autism, males and females, scientists and mathematicians</article-title><source>J Autism Dev Disord</source><year>2001</year><volume>31</volume><issue>1</issue><fpage>5</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1023/A:1005653411471</pub-id><pub-id pub-id-type="pmid">11439754</pub-id></element-citation></ref><ref id="CR108"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conners</surname><given-names>CK</given-names></name><name><surname>Erhardt</surname><given-names>D</given-names></name><name><surname>Epstein</surname><given-names>JN</given-names></name><name><surname>Parker</surname><given-names>JDA</given-names></name><name><surname>Sitarenios</surname><given-names>G</given-names></name><name><surname>Sparrow</surname><given-names>E</given-names></name></person-group><article-title>Self-ratings of ADHD symptoms in adults: I. Factor structure and normative data</article-title><source>J Atten Disord</source><year>1999</year><volume>3</volume><issue>3</issue><fpage>141</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1177/108705479900300303</pub-id></element-citation></ref><ref id="CR109"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Downes</surname><given-names>JJ</given-names></name><name><surname>Roberts</surname><given-names>AC</given-names></name><name><surname>Sahakian</surname><given-names>BJ</given-names></name><name><surname>Evenden</surname><given-names>JL</given-names></name><name><surname>Morris</surname><given-names>RG</given-names></name><name><surname>Robbins</surname><given-names>TW</given-names></name></person-group><article-title>Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson&#x02019;s disease: evidence for a specific attentional dysfunction</article-title><source>Neuropsychologia</source><year>1989</year><volume>27</volume><issue>11&#x02013;12</issue><fpage>1329</fpage><lpage>1343</lpage><pub-id pub-id-type="doi">10.1016/0028-3932(89)90128-0</pub-id><pub-id pub-id-type="pmid">2615934</pub-id></element-citation></ref><ref id="CR110"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norris</surname><given-names>G</given-names></name><name><surname>Tate</surname><given-names>RL</given-names></name></person-group><article-title>The Behavioural Assessment of the Dysexecutive Syndrome (BADS): Ecological, concurrent and construct validity</article-title><source>Neuropsychol Rehabil</source><year>2000</year><volume>10</volume><issue>1</issue><fpage>33</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1080/096020100389282</pub-id></element-citation></ref><ref id="CR111"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoekstra</surname><given-names>RA</given-names></name><name><surname>Vinkhuyzen</surname><given-names>AA</given-names></name><name><surname>Wheelwright</surname><given-names>S</given-names></name><name><surname>Bartels</surname><given-names>M</given-names></name><name><surname>Boomsma</surname><given-names>DI</given-names></name><name><surname>Baron-Cohen</surname><given-names>S</given-names></name><name><surname>Posthuma</surname><given-names>D</given-names></name><name><surname>van der Sluis</surname><given-names>S</given-names></name></person-group><article-title>The construction and validation of an abridged version of the autism-spectrum quotient (AQ-Short)</article-title><source>J Autism Dev Disord</source><year>2011</year><volume>41</volume><issue>5</issue><fpage>589</fpage><lpage>596</lpage><pub-id pub-id-type="doi">10.1007/s10803-010-1073-0</pub-id><pub-id pub-id-type="pmid">20697795</pub-id></element-citation></ref><ref id="CR112"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoekstra</surname><given-names>RA</given-names></name><name><surname>Bartels</surname><given-names>M</given-names></name><name><surname>Cath</surname><given-names>DC</given-names></name><name><surname>Boomsma</surname><given-names>DI</given-names></name></person-group><article-title>Factor structure, reliability and criterion validity of the Autism-Spectrum Quotient (AQ): a study in Dutch population and patient groups</article-title><source>J Autism Dev Disord</source><year>2008</year><volume>38</volume><issue>8</issue><fpage>1555</fpage><lpage>1566</lpage><pub-id pub-id-type="doi">10.1007/s10803-008-0538-x</pub-id><pub-id pub-id-type="pmid">18302013</pub-id></element-citation></ref><ref id="CR113"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fray</surname><given-names>PJ</given-names></name><name><surname>Robbins</surname><given-names>TW</given-names></name></person-group><article-title>CANTAB battery: proposed utility in neurotoxicology</article-title><source>Neurotoxicol Teratol</source><year>1996</year><volume>18</volume><issue>4</issue><fpage>499</fpage><lpage>504</lpage><pub-id pub-id-type="doi">10.1016/0892-0362(96)00027-X</pub-id><pub-id pub-id-type="pmid">8866544</pub-id></element-citation></ref><ref id="CR114"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luciana</surname><given-names>M</given-names></name></person-group><article-title>Practitioner review: computerized assessment of neuropsychological function in children: clinical and research applications of the Cambridge Neuropsychological Testing Automated Battery (CANTAB)</article-title><source>J Child Psychol Psychiatry</source><year>2003</year><volume>44</volume><issue>5</issue><fpage>649</fpage><lpage>663</lpage><pub-id pub-id-type="doi">10.1111/1469-7610.00152</pub-id><pub-id pub-id-type="pmid">12831110</pub-id></element-citation></ref><ref id="CR115"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robbins</surname><given-names>TW</given-names></name><name><surname>James</surname><given-names>M</given-names></name><name><surname>Owen</surname><given-names>AM</given-names></name><name><surname>Sahakian</surname><given-names>BJ</given-names></name><name><surname>McInnes</surname><given-names>L</given-names></name><name><surname>Rabbitt</surname><given-names>P</given-names></name></person-group><article-title>Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers</article-title><source>Dementia</source><year>1994</year><volume>5</volume><issue>5</issue><fpage>266</fpage><lpage>281</lpage><pub-id pub-id-type="pmid">7951684</pub-id></element-citation></ref><ref id="CR116"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oosterman</surname><given-names>JM</given-names></name><name><surname>Wijers</surname><given-names>M</given-names></name><name><surname>Kessels</surname><given-names>RP</given-names></name></person-group><article-title>Planning or something else? Examining neuropsychological predictors of Zoo Map performance</article-title><source>Appl Neuropsychol Adult</source><year>2013</year><volume>20</volume><issue>2</issue><fpage>103</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1080/09084282.2012.670150</pub-id><pub-id pub-id-type="pmid">23397996</pub-id></element-citation></ref><ref id="CR117"><label>117.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>J</given-names></name></person-group><source>Statistical power analysis for the behavioral sciences</source><year>1988</year><edition>2</edition><publisher-loc>Hillsdale</publisher-loc><publisher-name>L. Erlbaum Associates</publisher-name></element-citation></ref><ref id="CR118"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erdfelder</surname><given-names>E</given-names></name><name><surname>Faul</surname><given-names>F</given-names></name><name><surname>Buchner</surname><given-names>A</given-names></name></person-group><article-title>GPOWER: A general power analysis program</article-title><source>Behav Res Methods Instrum Comput</source><year>1996</year><volume>28</volume><issue>1</issue><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.3758/BF03203630</pub-id></element-citation></ref><ref id="CR119"><label>119.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Tchanturia</surname><given-names>K</given-names></name><name><surname>Davies</surname><given-names>H</given-names></name><name><surname>Reeder</surname><given-names>C</given-names></name><name><surname>Wykes</surname><given-names>T</given-names></name></person-group><source>Cognitive Remediation Programme for Anorexia Nervosa: A Manual for Practitioners</source><year>2010</year><publisher-loc>London</publisher-loc><publisher-name>Institute of Psychiatry</publisher-name></element-citation></ref><ref id="CR120"><label>120.</label><mixed-citation publication-type="other">van Passel B, Cath DC. Specialized Attention Therapy for patients with anorexia nervosa or obsessive compulsive disorder. In. Nijmegen: Radboud University; 2013.</mixed-citation></ref><ref id="CR121"><label>121.</label><mixed-citation publication-type="other">van Balkom A, van Vliet I, Emmelkamp P, Bockting C, Spijker J, Hermens M, Meeuwissen J. Multidisciplinaire richtlijn Angststoornissen. Richtlijn voor de diagnostiek, behandeling en begeleiding van volwassen pati&#x000eb;nten met een angststoornis. 3th revision. Utrecht: Trimbos-instituut; 2013.</mixed-citation></ref><ref id="CR122"><label>122.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wamel</surname><given-names>A</given-names></name><name><surname>Wassink</surname><given-names>M</given-names></name></person-group><source>Landelijk basisprogramma eetstoornissen</source><year>2006</year><publisher-loc>Utrecht</publisher-loc><publisher-name>Trimbos-instituut</publisher-name></element-citation></ref><ref id="CR123"><label>123.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Steketee</surname><given-names>G</given-names></name><name><surname>Barlow</surname><given-names>DH</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Barlow</surname><given-names>DH</given-names></name></person-group><article-title>Obsessive- compulsive disorder</article-title><source>Anxiety and its disorders: The nature and treatment of anxiety and panic</source><year>2002</year><publisher-loc>New York</publisher-loc><publisher-name>Guilford Press</publisher-name><fpage>516</fpage><lpage>676</lpage></element-citation></ref><ref id="CR124"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>March JS</surname><given-names>FA</given-names></name><name><surname>Carpenter</surname><given-names>D</given-names></name><name><surname>Kahn</surname><given-names>D</given-names></name></person-group><article-title>Treatment of obsesive-compulsive disorder: The Expert Consensus Panel for obsessive-compulsive disorder</article-title><source>J Clin Psychiatry</source><year>1997</year><volume>58</volume><issue>suppl 4</issue><fpage>2</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">9183300</pub-id></element-citation></ref><ref id="CR125"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellg</surname><given-names>AJ</given-names></name><name><surname>Borrelli</surname><given-names>B</given-names></name><name><surname>Resnick</surname><given-names>B</given-names></name><name><surname>Hecht</surname><given-names>J</given-names></name><name><surname>Minicucci</surname><given-names>DS</given-names></name><name><surname>Ory</surname><given-names>M</given-names></name><name><surname>Ogedegbe</surname><given-names>G</given-names></name><name><surname>Orwig</surname><given-names>D</given-names></name><name><surname>Ernst</surname><given-names>D</given-names></name><name><surname>Czajkowski</surname><given-names>S</given-names></name><etal/></person-group><article-title>Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH Behavior Change Consortium</article-title><source>Health Psychol</source><year>2004</year><volume>23</volume><issue>5</issue><fpage>443</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.1037/0278-6133.23.5.443</pub-id><pub-id pub-id-type="pmid">15367063</pub-id></element-citation></ref><ref id="CR126"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Preacher</surname><given-names>KJ</given-names></name><name><surname>Hayes</surname><given-names>AF</given-names></name></person-group><article-title>SPSS and SAS procedures for estimating indirect effects in simple mediation models</article-title><source>Behav Res Methods Instrum Comput</source><year>2004</year><volume>36</volume><issue>4</issue><fpage>717</fpage><lpage>731</lpage><pub-id pub-id-type="doi">10.3758/BF03206553</pub-id><pub-id pub-id-type="pmid">15641418</pub-id></element-citation></ref></ref-list></back></article>